Processing 00000000.tx.1: Mutation-dependent aggregation of tau protein and its selective depletion from the soluble fraction in brain of P301L FTDP-17 patients Patrizia Rizzu1,2, Marijke Joosse1, Rivka Ravid3, Andre Hoogeveen1, Wouter Kamphorst4, John C. van Swieten2, Rob Willemsen1 and Peter Heutink1,+ 1Department of Clinical Genetics and 2Department of Neurology, Erasmus University, PO Box 1738, 3000 DR Rotterdam, The Netherlands, 3The Netherlands Brain Bank, 1105 AZ Amsterdam, The Netherlands and 4Department of Pathology, Vrije University 1081 HV Amsterdam, The Netherlands Received 24 August 2000; 

Phrase: "Mutation-dependent aggregation of tau protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "its selective depletion from the soluble fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333668:Depletion [Functional Concept]

Phrase: "in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of P301L FTDP-17 patients Patrizia Rizzu1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Marijke Joosse1,"

Phrase: "Rivka Ravid3,"

Phrase: "Andre Hoogeveen1,"

Phrase: "Wouter Kamphorst4,"

Phrase: "John C. van Swieten2,"

Phrase: "Rob Willemsen1"

Phrase: "and"

Phrase: "Peter Heutink1,"

Phrase: "+ 1Department of Clinical Genetics"

Phrase: "and"

Phrase: "2Department of Neurology,"

Phrase: "Erasmus University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "PO Box 1738,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0179400:Box [Manufactured Object]
   827   C0442027:PO [Spatial Concept]
   827   C1533124:Box [Medical Device]

Phrase: "3000 DR Rotterdam,"

Phrase: "The Netherlands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "3The Netherlands Brain Bank,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442598:Bank [Manufactured Object]
   812   C0872261:Bank [Manufactured Object]

Phrase: "1105 AZ Amsterdam,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "and"

Phrase: "4Department of Pathology,"

Phrase: "Vrije University 1081 HV Amsterdam,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "24 August 2000"

Phrase: ";"
Processing 00000000.tx.2: Revised and Accepted 18 October 2000.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "18 October 2000."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Mutations in the gene for the microtubule-associated protein tau are associated with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Mutations in the gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0596611:gene mutations [Genetic Function]
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "for the microtubule-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "are"

Phrase: "associated with frontotemporal dementia"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0236642:frontotemporal dementia [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C0338451:Frontotemporal dementia [Disease or Syndrome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.4: In this study we compared the presence of the P301L mutated tau protein from brain material of patients with that of the normal 4-repeat, using polyclonal antibodies specific for the P301L point mutation and its normal counterpart. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the presence of the P301L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "tau protein from brain material of patients"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   774 E C1421563:protein tau [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "with that"

Phrase: "of the normal 4-repeat,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for the P301L point mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "its normal counterpart."
Processing 00000000.tx.5: We determined the relative ratio of mutated versus normal tau protein in the sarkosyl-soluble and -insoluble protein fractions from several brain regions. 

Phrase: "We"

Phrase: "determined"

Phrase: "the relative ratio of mutated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264683:Relative ratio [Quantitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "versus"

Phrase: "normal tau protein in the sarkosyl-soluble"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   774   C0860902:normal protein [Finding]
   774 E C1421563:protein tau [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "and -"

Phrase: "insoluble protein fractions from several brain regions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1264633:Fractions [Quantitative Concept]
   714 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.6: Although mutated and normal tau proteins are both present in the sarkosyl-insoluble deposits, quantitative analysis showed that the mutated protein is the major component. 

Phrase: "Although"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "and"

Phrase: "normal tau proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C0860902:normal protein [Finding]
   867 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "are"

Phrase: "both present in the sarkosyl-insoluble deposits,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the mutated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "the major component."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.7: In the sarkosyl-soluble fraction of frontal and temporal cortex the overall ratio of 3-repeat versus 4-repeat tau isoforms is unchanged but there is a dramatic depletion of mutant tau protein. 

Phrase: "In the sarkosyl-soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "of frontal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205123:Frontal [Spatial Concept]

Phrase: "and"

Phrase: "temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "the overall ratio of 3-repeat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "versus"

Phrase: "4-repeat tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "but"

Phrase: "there"

Phrase: "is"

Phrase: "a dramatic depletion of mutant tau protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333668:Depletion [Functional Concept]
Processing 00000000.tx.8: Furthermore, we observed an increase in tau-immunoreactive cleavage products with the P301L antibody, suggesting that the mutant protein is partly resistant to degradation and this is confirmed by pulsechase experiments. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an increase in tau-immunoreactive cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "with the P301L antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "partly resistant to degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "this"

Phrase: "is"

Phrase: "confirmed by pulsechase experiments."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0681814:Experiments [Research Activity]
   770   C0750484:Confirmed [Idea or Concept]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.9: This is the first direct evidence using patient material that shows a selective aggregation of mutant tau protein resulting in sarkosyl-insoluble deposits and the specific depletion of mutated tau protein in the soluble fraction.  

Phrase: "This"

Phrase: "is"

Phrase: "the first direct evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "patient material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "that"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a selective aggregation of mutant tau protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332621:Aggregation [Functional Concept]
   748   C0439168:% aggregation [Quantitative Concept]

Phrase: "resulting in sarkosyl-insoluble deposits"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0332294:Resulting in [Functional Concept]
   760   C0074071:sarkosyl [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0333562:Deposits [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "the specific depletion of mutated tau protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333668:Depletion [Functional Concept]

Phrase: "in the soluble fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The term frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), covers a number of neurodegenerative syndromes with diverse but overlapping clinical and neuropathological features. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The term frontotemporal dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0236642:frontotemporal dementia [Disease or Syndrome]
   901   C0338451:Frontotemporal dementia [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "covers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0180153:cover [Medical Device]
  1000   C1707529:Cover [Medical Device]
  1000   C1999244:Cover [Functional Concept]

Phrase: "a number of neurodegenerative syndromes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "with diverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diverse [Qualitative Concept]

Phrase: "but"

Phrase: "overlapping clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "neuropathological features."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.11: Early behavioral changes, later accompanied by cognitive and motor disturbances, and often by atrophy in the frontal and temporal lobes on neuroimaging, are characteristic for this condition (1,2). 

Phrase: "Early behavioral changes,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0542299:Behavioral changes [Individual Behavior]
   827   C0004927:Behavioral [Individual Behavior]
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   827   C2986890:Behavioral [Idea or Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "later"

Phrase: "accompanied by cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516691:Cognitive [Functional Concept]

Phrase: "and"

Phrase: "motor disturbances,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2699787:Disturbance [Qualitative Concept]

Phrase: "and"

Phrase: "often by atrophy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332183:Often [Temporal Concept]
   790   C0333641:Atrophy [Pathologic Function]
   718 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "in the frontal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205123:Frontal [Spatial Concept]

Phrase: "and"

Phrase: "temporal lobes on neuroimaging,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0039485:TEMPORAL LOBES [Body Part, Organ, or Organ Component]
   799 E C1268978:Temporal lobe [Body Part, Organ, or Organ Component]
   770   C0442043:Temporal [Spatial Concept]
   770   C0796494:lobes [Body Part, Organ, or Organ Component]
   770   C2362314:Temporal [Temporal Concept]
   737 E C1428707:Lobe [Gene or Genome]
   737 E C3539671:Lobe [Gene or Genome]

Phrase: "are"

Phrase: "characteristic for this condition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Pathological hallmarks of most FTDP-17 brains are insoluble filamentous aggregates of hyperphosphorylated protein tau, in neurons or in both neurons and glial cells, similar to those found in other neurodegenerative disorders such as Alzheimers disease (AD), Pick s disease, progressive supranuclear palsy, corticobasal degeneration and amyothrophic lateral sclerosis (ALS), Parkinsonism-dementia complex of Guam (3). 

Phrase: "Pathological hallmarks of most FTDP-17 brains"

Phrase: "are"

Phrase: "insoluble filamentous aggregates of hyperphosphorylated protein tau,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205418:aggregates [Qualitative Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "or in both neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "and"

Phrase: "glial cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found in other neurodegenerative disorders"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   806   C1522560:Neurodegenerative Disorders [Functional Concept]
   760   C0012634:Disorders [Disease or Syndrome]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]

Phrase: "such as Alzheimers disease (AD),"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Pick s disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C0236642:Pick's Disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "progressive supranuclear palsy,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0038868:Progressive supranuclear palsy [Disease or Syndrome]
   901   C0270920:Supranuclear palsy [Disease or Syndrome]
   885   C0205858:PARALYSIS, PROGRESSIVE [Disease or Syndrome]
   827   C0205329:Progressive [Functional Concept]
   827   C0522224:Palsy [Finding]

Phrase: "corticobasal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0393570:Corticobasal degeneration [Disease or Syndrome]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "amyothrophic lateral sclerosis (ALS),"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0154682:Lateral Sclerosis [Disease or Syndrome]
   827   C0036429:Sclerosis [Pathologic Function]
   827   C0205093:Lateral [Spatial Concept]
   755 E C0334135:Sclerotic [Functional Concept]

Phrase: "Parkinsonism-dementia complex of Guam"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0242422:Parkinsonism [Disease or Syndrome]
   760   C0439855:Complex [Qualitative Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Genetic analysis of FTDP-17 has revealed that the disorder is caused by mutations in the gene for the microtubule-associated protein tau (46). 

Phrase: "Genetic analysis of FTDP-17"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0679560:genetic analysis [Laboratory Procedure]
   806   C0796344:Genetic Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "has"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the disorder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorder [Disease or Syndrome]

Phrase: "is"

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "for the microtubule-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.14: The tau protein is encoded by a single gene but, due to differential RNA splicing, is expressed in the adult human brain in six isoforms. 

Phrase: "The tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "encoded by a single gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0017337:Gene [Gene or Genome]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0679058:encoded [Mental Process]
   760   C2700640:Encoded [Activity]

Phrase: "but"

Phrase: ","

Phrase: "due to differential RNA splicing,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035687:RNA Splicing [Genetic Function]
           Splicing
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C2610186:splicing [Genetic Function]

Phrase: "is"

Phrase: "expressed in the adult human brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0001675:Human, Adult [Age Group]
           Adult
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0086418:Human [Human]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1706450:Adult [Human]

Phrase: "in six isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.15: These isoforms differ by the presence of three or four imperfect repeats in the C-terminus, which are part of the microtubule-binding region and by the presence or absence of two N-terminal inserts of 29 and 58 amino acids (7). 

Phrase: "These isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "differ by the presence of three"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205449:Three [Quantitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "four imperfect"

Phrase: "repeats in the C-terminus,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   760   C0205341:Repeat [Functional Concept]
   760   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C1707522:Cerebellum [Tissue]

Phrase: "which"

Phrase: "are"

Phrase: "part of the microtubule-binding region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1183338:Part of microtubule [Cell Component]
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and by the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1515981:And [Idea or Concept]

Phrase: "or"

Phrase: "absence of two N-terminal inserts of 29"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "58 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.16: The tau protein regulates the dynamic stability of the neuronal cytoskeleton and plays an important role in neuronal differentiation and axonal development (8) through its ability to promote microtubule assembly. 

Phrase: "The tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "regulates"

Phrase: "the dynamic stability of the neuronal cytoskeleton"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stability [Qualitative Concept]
   748   C2347098:Stability [Qualitative Concept]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in neuronal differentiation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "axonal development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "(8"

Phrase: ")"

Phrase: "through its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "microtubule assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.17: Moreover, tau protein is involved in positioning of cell organelles, axonal transport and the maintenance of neuron polarity (912). 

Phrase: "Moreover,"

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "involved in positioning of cell organelles,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0029219:cell organelles [Cell Component]
           Organelles
   753   C0007634:Cell [Cell]
   753   C0150305:positioning [Therapeutic or Preventive Procedure]
   753   C0733755:Positioning [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1314939:Involved [Functional Concept]
   753   C1561964:Positioning [Health Care Activity]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]

Phrase: "and"

Phrase: "the maintenance of neuron polarity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C2610689:neuron maintenance [Cell Function]
   760   C0024501:Maintenance [Activity]

Phrase: "(912"

Phrase: ")."
Processing 00000000.tx.18: The mutations identified in the tau gene are localized both in the coding and non-coding sequences of the gene (13). 

Phrase: "The mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in the tau gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0017337:Gene [Gene or Genome]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "are"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "both in the coding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0009219:Coding [Occupational Activity]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "non-coding sequences of the gene"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   756   C0079941:Coding Sequence [Gene or Genome]
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.19: The intronic mutations are all located close to the 5' splice-donor site of the intron following exon 10. 

Phrase: "The intronic mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1881250:Intronic Mutation [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "all"

Phrase: "located"

Phrase: "close to the 5' splice-donor site of the intron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0587267:Close [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exon 10."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.20: In addition, several mutations within exon 10 have been shown to cause a shift in the normal splicing ratio of transcripts containing exon 10, mostly resulting in an increased ratio of 4-repeat (4R) with respect to 3-repeat (3R) tau (4,6,1416). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "several mutations within exon 10"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a shift in the normal splicing ratio of transcripts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0333051:Shift [Functional Concept]
   742   C2347509:Shift [Phenomenon or Process]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "exon 10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mostly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750554:mostly [Idea or Concept]

Phrase: "resulting in an increased ratio of 4-repeat (4R)"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0332294:Resulting in [Functional Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0205341:Repeat [Functional Concept]
   744   C0442805:Increased [Functional Concept]
   744   C0456603:Ratio [Quantitative Concept]
   744   C0678226:resulting [Functional Concept]
   744   C1547037:Ratio [Intellectual Product]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "with respect to 3-repeat (3R) tau"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0205341:Repeat [Functional Concept]
   827   C0439086:<3 [Quantitative Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: "(4,"

Phrase: "6,"

Phrase: "1416"

Phrase: ")."
Processing 00000000.tx.21: The missense mutations and a small deletion are localized in the C-terminal part of the protein containing the microtubule-binding domains and are likely to alter taus interactions with tubulin. 

Phrase: "The missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "a small deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "are"

Phrase: "localized in the C-terminal part of the protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   784   C1268145:Part of cerebellum [Body Part, Organ, or Organ Component]
   764   C1292711:Part of [Spatial Concept]
   742   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205088:Terminal [Temporal Concept]
   742   C0392752:Localized [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1707522:Cerebellum [Tissue]
   742   C1709471:Part [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the microtubule-binding domains"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C1149274:microtubule binding [Molecular Function]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "taus interactions with tubulin."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C1373147:Tubulin Interactions [Molecular Function]
   802 E C3537022:Tubulin Interaction [Molecular Function]
   737   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.22: The mutations in exon 10 only affect the 4R tau isoforms, but other mutations affect both 3R and 4R tau isoforms. 

Phrase: "The mutations in exon 10 only"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the 4R tau isoforms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "but"

Phrase: "other mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "both 3R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "4R tau isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.23: The P301L mutation in FTDP-17 kindreds has been most extensively described (4,1721). 

Phrase: "The P301L mutation in FTDP-17 kindreds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "been"

Phrase: "most extensively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(4,"

Phrase: "1721"

Phrase: ")."
Processing 00000000.tx.24: Perinuclear deposits of hyperphosphorylated tau are seen in neurons, glial cells and neurites of frontal and temporal cortex, hippocampal formation and substantia nigra in brains of P301L patients. 

Phrase: "Perinuclear deposits of hyperphosphorylated tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "seen in neurons,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "glial cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0027836:Glial Cells [Cell]
           Glial
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C1087003:Glia [Plant]

Phrase: "and"

Phrase: "neurites of frontal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0085103:Neurites [Cell Component]

Phrase: "and"

Phrase: "temporal cortex,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "hippocampal formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175202:Hippocampal Formation [Body Part, Organ, or Organ Component]
   861   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "substantia nigra in brains of P301L patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   788   C0038590:BRAIN, SUBSTANTIA NIGRA [Body Part, Organ, or Organ Component]
           Substantia Nigra
   778   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.25: The deposits consist of slender twisted filaments 15 nm wide with variable periodicity and a few straight filaments (22). 

Phrase: "The deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposits [Functional Concept]

Phrase: "consist of slender"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332529:CONSIST [Qualitative Concept]

Phrase: "twisted"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0231467:Twisted [Spatial Concept]
   966 E C0040480:twist [Physiologic Function]
   928 E C0231458:Rotated [Spatial Concept]
   907 E C1265748:Twisting [Pathologic Function]
   907 E C1881716:TWISTING [Phenomenon or Process]

Phrase: "filaments 15 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "wide with variable periodicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332464:Wide [Spatial Concept]

Phrase: "and"

Phrase: "a few straight filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.26: Tau extracted from these filaments appears on immunoblot as two major bands of 64 and 68 kDa and a minor band of 72 kDa, that after alkaline phosphatase treatment can be resolved in two 4R (4R, 4R + 28 amino acids) and one 3R tau isoforms (3R + 28 amino acids). 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "extracted from these filaments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C3541890:EXTRACTED [Finding]
   737   C0010851:Filament [Cell Component]
   737 E C2828366:Extract [Substance]

Phrase: "appears on immunoblot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblot [Laboratory Procedure]
   790   C0700364:APPEAR [Qualitative Concept]

Phrase: "as two major bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "of 64"

Phrase: "and"

Phrase: "68 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "a minor band of 72 kDa,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "that"

Phrase: "after"

Phrase: "alkaline phosphatase treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "can"

Phrase: "be"

Phrase: "resolved in two 4R"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205341:Repeat [Functional Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C1514893:Resolved [Idea or Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C2699488:Resolved [Conceptual Entity]

Phrase: "(4R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "4R + 28 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "one 3R tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(3R + 28 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.27: The proline residue at codon 301 is part of a highly evolutionary conserved PGGG motif that is found in all microtubule-binding repeats and is located in the microtubulebinding repeat specific for 4R tau. 

Phrase: "The proline residue at codon 301"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "is"

Phrase: "part of a highly evolutionary conserved PGGG motif"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1292711:Part of [Spatial Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1709471:Part [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "found in all microtubule-binding repeats"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C1149274:microtubule binding [Molecular Function]
   753   C0026046:Micro-tubule [Cell Component]
   753   C0150312:Found [Quantitative Concept]
   753   C0205341:repeats [Functional Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1705914:Repeats [Conceptual Entity]
   719 E C0243095:Find [Finding]
   719 E C1547730:Repeat [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "located in the microtubulebinding repeat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205341:Repeat [Functional Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]

Phrase: "specific for 4R tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
Processing 00000000.tx.28: Several studies (15,16,23,24) have been performed to investigate the possible effect of the tau mutations on microtubule polymerization and binding and the results indeed showed impairment in these parameters. 

Phrase: "Several studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(15,"

Phrase: "16,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the possible effect of the tau mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on microtubule polymerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1156032:Microtubule Polymerization [Cell Function]
   861   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "and"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "the results indeed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "impairment in these parameters."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.29: Tau filaments, similar to those found in brains of patients, can be generated in vitro as well. 

Phrase: "Tau filaments,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found in brains of patients,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0150312:Found [Quantitative Concept]
   726 E C0243095:Find [Finding]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "can"

Phrase: "be"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "in vitro as well."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.30: 4R tau aggregates more readily than 3R tau and, compared with this, tau with missense mutations aggregates even faster. 

Phrase: "4R tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "more readily than 3R tau"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C2362079:TAU 3 [Immunologic Factor]
   753   C0205172:More [Functional Concept]
   753   C0205341:Repeat [Functional Concept]
   753   C1547730:Repeat [Temporal Concept]
   753   C1705914:Repeat [Conceptual Entity]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: ","

Phrase: "compared with this,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "tau with missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "even faster."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015663:Fast [Finding]
   827   C0456962:Fast [Qualitative Concept]
Processing 00000000.tx.31: Results from three independent studies demonstrate that the P301L mutation has a high potential for fibril formation (2527). 

Phrase: "Results from three independent studies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results studies [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the P301L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "a high potential for fibril formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "(2527"

Phrase: ")."
Processing 00000000.tx.32: Until now, however, it has not been shown that the P301L mutated tau protein has these properties in vivo. 

Phrase: "Until"

Phrase: "now,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "however,"

Phrase: "it"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the P301L"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "has"

Phrase: "these properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.33: For the present study, we developed specific rabbit polyclonal antibodies raised against the P301L point mutation and its normal counterpart and showed that although both normal 4R and mutated P301L tau are present in the insoluble deposits of the cerebral cortex, the main component of these deposits is the mutated tau protein. 

Phrase: "For the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "developed"

Phrase: "specific rabbit polyclonal antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   886   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised against the P301L point mutation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   753   C0026882:Mutation [Genetic Function]
   753   C0442818:Raised [Quantitative Concept]
   753   C1552961:Point [Quantitative Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "its normal counterpart"

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "although"

Phrase: "both normal 4R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "mutated P301L tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "are"

Phrase: "present in the insoluble deposits of the cerebral cortex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "the main component of these deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "the mutated tau protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]
Processing 00000000.tx.34: Conversely, in the soluble fraction we observed a strong reduction in the level of mutated P301L protein, especially in the frontal cortex. 

Phrase: "Conversely,"

Phrase: "in the soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a strong reduction in the level of mutated P301L protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "especially in the frontal cortex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0205123:Frontal [Spatial Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
Processing 00000000.tx.35: These findings suggest that the low level of mutated protein in the soluble fraction is due to a selective depletion, resulting from the selective aggregation of mutant protein in the sarkosyl-insoluble deposits. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the low level of mutated protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0748025:Low protein level [Finding]
           low protein
   783   C0242972:low protein [Therapeutic or Preventive Procedure]
   783   C0428479:Protein level [Laboratory or Test Result]
   753   C0205251:low [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1299352:Low [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C1550472:low [Idea or Concept]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "in the soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "is due to a selective depletion,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0333668:Depletion [Functional Concept]
   753   C3146286:Due [Idea or Concept]

Phrase: "resulting from the selective aggregation of mutant protein"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332621:Aggregation [Functional Concept]
   744   C0439168:% aggregation [Quantitative Concept]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   744   C0678226:resulting [Functional Concept]
   731   C0428635:Protein selectivity [Laboratory Procedure]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]

Phrase: "in the sarkosyl-insoluble deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.36: In addition, we observed an increase of tau-immunoreactive cleavage products for the mutant protein compared with the normal protein, strongly suggesting that an inappropriate digestion of the mutated protein plays an important role in the pathogenesis of FTDP-17 as well.  

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "an increase of tau-immunoreactive cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "for the mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "compared with the normal protein,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0860902:normal protein [Finding]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "an inappropriate digestion of the mutated protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1523943:protein digestion [Organism Function]
   774   C2349986:Protein Digestion [Research Activity]
           Digestion
   748   C0012238:Digestion [Organism Function]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the pathogenesis of FTDP-17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "as well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.37: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Characterization of the antibodies tau-P301 and tau-P301L To determine the specificity of tau-P301 and tau-P301L antibodies, transient and stable transfection experiments were performed using COS and PC12 cell lines. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Characterization of the antibodies tau-P301"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "tau-P301L To"

Phrase: "determine"

Phrase: "the specificity of tau-P301"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "and"

Phrase: "tau-P301L antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "transient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040704:Transient [Population Group]
  1000   C0205374:Transient [Temporal Concept]

Phrase: "and"

Phrase: "stable transfection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "COS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454802:Cos [Geographic Area]

Phrase: "and"

Phrase: "PC12 cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   901   C0085262:PC12 Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.38: Immunocytochemical (Fig. 1) and immunoblot (Fig. 2A and B) analyses showed that the tau-P301 and tau-P301L antibodies specifically recognize the normal 4R tau or the P301L mutant protein, respectively. 

Phrase: "Immunocytochemical"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(Fig. 2A"

Phrase: "and"

Phrase: "B) analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the tau-P301"

Phrase: "and"

Phrase: "tau-P301L antibodies specifically"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognize"

Phrase: "the normal 4R tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205341:Repeat [Functional Concept]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "or"

Phrase: "the P301L mutant protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "respectively."
Processing 00000000.tx.39: View larger version (24K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.40: PC12 stably transfected cells with normal 4R (A and C) and mutant P301L tau (B and D) were stained with tau-P301 antibody (A and B) and tau-P301L antibody (C and D).  

Phrase: "PC12 stably transfected cells with normal 4R"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C0085262:PC12 Cells [Cell]
   750   C0007634:Normal cell [Cell]
           Cells
   750   C1268443:Normal cell [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(A"

Phrase: "and"

Phrase: "C"

Phrase: ")"

Phrase: "and"

Phrase: "mutant P301L tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "D)"

Phrase: "were"

Phrase: "stained with tau-P301 antibody"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "tau-P301L antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.41: View larger version (47K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.42: Immunoblot of COS cells transfected with normal 4R and mutated P301L tau and incubated with tau-P301 (A) and tau-P301L (B) antibodies. 

Phrase: "Immunoblot of COS cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "transfected with normal 4R"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205307:Normal [Qualitative Concept]
   760   C0205341:Repeat [Functional Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutated P301L tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "incubated with tau-P301"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "(A)"

Phrase: "and"

Phrase: "tau-P301L"

Phrase: "(B) antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0368720:B Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.43: (C) Autoradiograph of SDSPAGE gel showing P301L mutated and normal 4R tau proteins synthesized by in vitro transcription and translation in the presence of [35S]methionine. 

Phrase: "(C"

Phrase: ")"

Phrase: "Autoradiograph of SDSPAGE gel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2986957:Autoradiograph [Manufactured Object]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "P301L"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "and"

Phrase: "normal 4R tau proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   881   C0860902:normal protein [Finding]
   840   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synthesized by in vitro transcription"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0040649:Transcription [Genetic Function]
   760   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "translation in the presence of [35S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040712:Translation [Intellectual Product]
   753   C0597295:translation [Molecular Function]
   753   C1519614:Translation [Genetic Function]

Phrase: "]methionine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.44: The two bands seen in each lane might be the result of an additional translation initiation due to the presence of a second methionine 10 amino acids downstream from the first. 

Phrase: "The two bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "seen in each lane"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205397:Seen [Qualitative Concept]
   770   C1708639:Lane [Spatial Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "might"

Phrase: "be"

Phrase: "the result of an additional translation initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "due to the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of a second methionine 10 amino acids"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C0020931:Amino Acids, Secondary [Amino Acid, Peptide, or Protein]
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "downstream from the first."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]
Processing 00000000.tx.45: (D) Immunoblot of in vitro synthesized P301L mutated and normal 4R tau proteins, detected with tau-P301L and tau-P301 antibodies, respectively. 

Phrase: "("

Phrase: "D)"

Phrase: "Immunoblot of in vitro synthesized P301L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "and"

Phrase: "normal 4R tau proteins,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   881   C0860902:normal protein [Finding]
   840   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "detected with tau-P301L"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "tau-P301 antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.46: The bands indicated by an arrow were quantified to compare the strength of both antibodies.  

Phrase: "The bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "indicated by an arrow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]

Phrase: "were"

Phrase: "quantified"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the strength of both antibodies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237897:Strength [Quantitative Concept]
   760   C0808080:Strength [Idea or Concept]
   760   C1705922:Strength [Qualitative Concept]
Processing 00000000.tx.47: In order to compare the strength of the tau-P301 and tau-P301L antibodies, both normal and mutant P301L tau (longest isoform), were synthesized by in vitro transcription and translation in the presence of [35S]methionine. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the strength of the tau-P301"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0237897:Strength [Quantitative Concept]
   753   C0808080:Strength [Idea or Concept]
   753   C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "tau-P301L antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "both normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutant P301L tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(longest isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "synthesized by in vitro transcription"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0040649:Transcription [Genetic Function]
   760   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "translation in the presence of [35S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040712:Translation [Intellectual Product]
   753   C0597295:translation [Molecular Function]
   753   C1519614:Translation [Genetic Function]

Phrase: "]methionine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.48: Identical amounts of both tau proteins were loaded on SDSpolyacrylamide gel, blotted (Fig. 2C) and incubated with tau-P301 and tau-P301L antibodies (using the same dilutions), respectively (Fig. 2D). 

Phrase: "Identical amounts of both tau proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "loaded on SDSpolyacrylamide gel,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "blotted"

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "and"

Phrase: "incubated with tau-P301"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "tau-P301L antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same dilutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0079240:dilutions [Laboratory Procedure]
   827 E C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively"

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.49: Quantitative analysis showed that the ratio tau-P301L:tau-P301 was 0.86; 

Phrase: "Quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the ratio tau-P301L"

Phrase: ":"

Phrase: "tau-P301"

Phrase: "was"

Phrase: "0.86"

Phrase: ";"
Processing 00000000.tx.50: thus, no significant difference was found in the binding of the two antibodies to their respective epitopes, making them suitable for quantitative western blots studies. 

Phrase: "thus,"

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "found in the binding of the two antibodies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0150312:Found [Quantitative Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   711 E C0243095:Find [Finding]

Phrase: "to their respective epitopes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "them suitable for quantitative western blots"

Phrase: "studies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.51: Histochemical analysis of mutated and normal tau proteins In patients carrying the P301L mutation, the tau-P301 and the tau-P301L antibodies gave a similar staining patterns in brain slides from the cerebral cortex and the hippocampus. 

Phrase: "Histochemical analysis of mutated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "normal tau proteins In patients"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0860902:normal protein [Finding]
   781 E C1421563:protein tau [Gene or Genome]
   773 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the P301L mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the tau-P301"

Phrase: "and"

Phrase: "the tau-P301L antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a similar staining patterns in brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0449778:patterns staining [Spatial Concept]
   753   C0449774:Patterns [Spatial Concept]

Phrase: "slides from the cerebral cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C0444330:Slide [Research Device]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C1705201:Slide [Manufactured Object]
   760   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "the hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.52: They recognized especially the aggregates in the superficial layers 23 and deep layer 6 of the temporal cortex (Fig. 3A) and to a lesser extent aggregates in the frontal and entorhinal cortex. 

Phrase: "They"

Phrase: "recognized"

Phrase: "especially"

Phrase: "the aggregates in the superficial layers 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "deep layer 6 of the temporal cortex"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   748   C0007776:Cortex [Body Part, Organ, or Organ Component]
   748   C0205125:Deep [Spatial Concept]
   748   C0442043:Temporal [Spatial Concept]
   748   C0934502:Layer [Body Part, Organ, or Organ Component]
   748   C1176472:Cortex [Body Part, Organ, or Organ Component]
   748   C1522408:Layer [Qualitative Concept]
   748   C1561599:Layer [Intellectual Product]
   748   C2362314:Temporal [Temporal Concept]
   748   C2700441:Cortex [Plant]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: "and to a lesser extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "aggregates in the frontal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205123:Frontal [Spatial Concept]
   770   C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "entorhinal cortex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
  1000   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]
Processing 00000000.tx.53: These aggregates were mainly located in the perinuclear region, cell body and sometimes extending to the apical dendrites of neurons. 

Phrase: "These aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "mainly"

Phrase: "located in the perinuclear region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "cell body"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0599444:Cell body [Cell Component]
  1000   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "extending to the apical dendrites of neurons."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   762   C3548420:apical dendrite [Cell Component]
   748   C0011305:Dendrites [Cell Component]
   748   C0027882:Neurons [Cell]
   748   C0205111:Apical [Spatial Concept]
   748   C0439792:Extending [Spatial Concept]
   714 E C0231448:Extend [Functional Concept]
Processing 00000000.tx.54: In one patient occasionally a diffuse staining with both antibodies was observed in the axons. 

Phrase: "In one patient occasionally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:*^patient [Patient or Disabled Group]

Phrase: "a diffuse staining with both antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "observed in the axons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004461:Axons [Cell Component]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.55: Tau-P301L antibody did not show any signal in AD brain (Fig. 3B), non-demented control and R406W cases. 

Phrase: "Tau-P301L antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any signal in AD brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "non-demented control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "R406W cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.56: View larger version (146K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(146K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.57: Sections of the temporal cortex of P301L patient 3 (A) and an AD patient (B) stained with tau-P301L antibody. 

Phrase: "Sections of the temporal cortex of P301L patient 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   745   C0554924:patient section [Finding]
   708   C0205155:Section [Spatial Concept]
   708   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   708   C1522472:Section [Substance]
   708   C1552923:Section [Quantitative Concept]
   708   C1705191:Section [Physical Object]

Phrase: "(A)"

Phrase: "and"

Phrase: "an AD patient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:*^patient [Patient or Disabled Group]
   734   C0002395:Alzheimers disease [Disease or Syndrome]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "stained with tau-P301L antibody."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.58: Magnification, x40.  

Phrase: "Magnification,"

Phrase: "x40."
Processing 00000000.tx.59: Biochemical analysis of mutated and normal tau proteins Sarkosyl-insoluble tau, isolated from frontal cortex, temporal cortex and cerebellum of three patients carrying the P301L mutation, one AD patient and one disinhibition dementia Parkinsonism amyotrophy complex (DDPAC) patient, was run on an SDSPAGE gel and immunoblotted with the antibodies H-7, tau-P301 and tau-P301L. 

Phrase: "Biochemical analysis of mutated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "normal tau proteins Sarkosyl-insoluble tau,"

Phrase: "isolated from frontal cortex,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   770   C0007776:Cortex [Body Part, Organ, or Organ Component]
   770   C0205123:Frontal [Spatial Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   770   C2700441:Cortex [Plant]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "cerebellum of three patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1707522:Cerebellum [Tissue]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the P301L mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "one AD patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "one disinhibition dementia Parkinsonism amyotrophy complex (DDPAC) patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0030705:*^patient [Patient or Disabled Group]

Phrase: "was"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "an SDSPAGE gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "immunoblotted with the antibodies H-7,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   773   C0369286:antibody h [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "tau-P301"

Phrase: "and"

Phrase: "tau-P301L."
Processing 00000000.tx.60: With H-7 and tau-P301 antibodies, three major bands (60, 64 and 68 kDa) were seen in the AD patient and two bands (64 and 68 kDa) in the DDPAC patient. 

Phrase: "With H-7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "tau-P301 antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "three major bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "(60,"

Phrase: "64"

Phrase: "and"

Phrase: "68 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "were"

Phrase: "seen in the AD patient"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0002395:Alzheimers disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0030705:*^patient [Patient or Disabled Group]
   753   C0205397:Seen [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "two bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "(64"

Phrase: "and"

Phrase: "68 kDa) in the DDPAC patient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.61: These brains did not show any signal with the tau-P301L antibody, as expected (Fig. 4A). 

Phrase: "These brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any signal with the tau-P301L antibody,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.62: View larger version (99K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(99K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.63: (A). 

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.64: Immunoblot of sarkosyl-insoluble tau from the frontal cortex of one AD, one DDPAC and three FTDP-17 patients carrying the P301L mutation (P301L1, P301L2 and P301L3), using the phosphorylation independent antibody H-7, the tau-P301 and the tau-P301L antibodies. 

Phrase: "Immunoblot of sarkosyl-insoluble tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "from the frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of one AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "one DDPAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "three FTDP-17 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the P301L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(P301L1,"

Phrase: "P301L2"

Phrase: "and"

Phrase: "P301L3"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the phosphorylation independent antibody H-7,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   840   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   840   C0369286:antibody h [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0031715:Phosphorylation [Molecular Function]
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0085862:Independent [Idea or Concept]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]
   804   C1158886:Phosphorylation [Molecular Function]
   804   C1299583:Independent [Finding]

Phrase: "the tau-P301"

Phrase: "and"

Phrase: "the tau-P301L antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.65: (B) Immunoblot of sarkosyl-insoluble tau from the frontal cortex of the three P301L patients after alkaline phosphatase treatment, stained with the phosphorylation-independent antibody H-7. 

Phrase: "(B) Immunoblot of sarkosyl-insoluble tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "from the frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of the three P301L patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "after alkaline phosphatase treatment,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "stained with the phosphorylation-independent antibody H-7."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   770   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   770   C0369286:antibody h [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0085862:Independent [Idea or Concept]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1299583:Independent [Finding]
   744   C2986582:Stained [Qualitative Concept]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.66: (C) Ratio between the relative amounts of mutated P301L protein and normal 4R tau in the sarkosyl-insoluble deposits from the frontal lobe.  

Phrase: "(C"

Phrase: ")"

Phrase: "Ratio between the relative amounts of mutated P301L protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1264683:Relative ratio [Quantitative Concept]
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "normal 4R tau in the sarkosyl-insoluble deposits"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C2362080:TAU 4 [Immunologic Factor]
   742   C0205341:Repeat [Functional Concept]
   742   C1547730:Repeat [Temporal Concept]
   742   C1705914:Repeat [Conceptual Entity]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]

Phrase: "from the frontal lobe."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0016733:frontal lobe [Body Part, Organ, or Organ Component]
  1000   C1268977:Frontal lobe [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C0796494:lobe [Body Part, Organ, or Organ Component]
   861   C1428707:Lobe [Gene or Genome]
   861   C3539671:Lobe [Gene or Genome]
   789 E C1522010:Lobar [Qualitative Concept]
Processing 00000000.tx.67: In the material extracted from frontal cortex of the P301L patients, all three antibodies recognized two major bands of 64 and 68 kDa and a minor band of 72 kDa, with the 68 kDa band being the strongest (Fig. 4A). 

Phrase: "In the material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Material [Substance]

Phrase: "extracted from frontal cortex of the P301L patients,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   744   C0007776:Cortex [Body Part, Organ, or Organ Component]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C0205123:Frontal [Spatial Concept]
   744   C1176472:Cortex [Body Part, Organ, or Organ Component]
   744   C2700441:Cortex [Plant]
   744   C3541890:EXTRACTED [Finding]
   711 E C2828366:Extract [Substance]

Phrase: "all three antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognized"

Phrase: "two major bands of 64"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "68 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "a minor band of 72 kDa,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "with the 68 kDa band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "being"

Phrase: "the strongest"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.68: After alkaline phosphatase treatment of the material from P301L patients and staining with H-7 antibody, the insoluble tau was resolved into four bands corresponding to the 4R, 3R + 29 amino acids, 4R + 29 amino acids and 4R + 58 amino acids isoforms (Fig. 4B). 

Phrase: "After alkaline phosphatase treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "of the material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Material [Substance]

Phrase: "from P301L patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "staining with H-7 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "the insoluble tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "resolved into four bands"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0175723:Bands [Medical Device]
   770   C0205450:Four [Quantitative Concept]
   770   C1514893:Resolved [Idea or Concept]
   770   C2699488:Resolved [Conceptual Entity]
   737 E C0439645:Band [Spatial Concept]
   737 E C1521913:band [Cell Component]

Phrase: "corresponding to the 4R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205341:Repeat [Functional Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]

Phrase: "3R + 29 amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "4R + 29 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "4R + 58 amino acids isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.69: The bands corresponding to the 4R and to the 4R + 29 amino acids appeared to be the strongest. 

Phrase: "The bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "corresponding to the 4R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205341:Repeat [Functional Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]

Phrase: "and to the 4R + 29 amino acids"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   793   C0771098:AMINO ACIDS 4% [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0001128:Acids [Chemical]
   744   C0205341:Repeat [Functional Concept]
   744   C1515981:And [Idea or Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]
   737 E C2917660:Amino Acid [Pharmacologic Substance]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the strongest."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]
Processing 00000000.tx.70: Quantitative analysis was used to determine the relative amount of mutated tau-P301L protein in the insoluble deposits for all the three patients with the P301L mutation (Fig. 4C). 

Phrase: "Quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the relative amount of mutated tau-P301L protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "in the insoluble deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "for all"

Phrase: "the three patients with the P301L mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.71: The P301L mutated tau protein was found to be on average four times more abundant than the normal 4R tau. 

Phrase: "The P301L"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be on average four times"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0040223:times [Temporal Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C1510992:Average [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "more abundant than the normal 4R tau."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2346714:Abundant [Qualitative Concept]
Processing 00000000.tx.72: These results show that in the sarkosyl-insoluble deposits of the frontal cortex both normal 4R and mutated P301L tau protein are present, but that 4R protein consists mainly of mutated P301L protein. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in the sarkosyl-insoluble deposits of the frontal cortex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   739   C0007776:Cortex [Body Part, Organ, or Organ Component]
   739   C0074071:sarkosyl [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0205123:Frontal [Spatial Concept]
   739   C0333562:Deposits [Functional Concept]
   739   C1176472:Cortex [Body Part, Organ, or Organ Component]
   739   C2700441:Cortex [Plant]

Phrase: "both normal 4R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "mutated P301L tau protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "are"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "that 4R protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "consists"

Phrase: "mainly of mutated P301L protein."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1705285:Mutated [Cell or Molecular Dysfunction]
   726 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.73: Similar experiments performed on the sarkosyl-insoluble tau isolated from the temporal cortex showed that also in tau deposits of the temporal lobe the mutated tau is the major 4R tau component. 

Phrase: "Similar experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed on the sarkosyl-insoluble tau"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0074071:sarkosyl [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0884358:Performed [Functional Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "isolated from the temporal cortex"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0205409:Isolated [Functional Concept]
   760   C0442043:Temporal [Spatial Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C1548221:Isolated [Idea or Concept]
   760   C2362314:Temporal [Temporal Concept]
   760   C2700441:Cortex [Plant]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that also in tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "deposits of the temporal lobe"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0039485:Temporal Lobe [Body Part, Organ, or Organ Component]
   806   C1268978:Temporal lobe [Body Part, Organ, or Organ Component]
   760   C0333562:Deposit [Functional Concept]
   760   C0442043:Temporal [Spatial Concept]
   760   C0796494:lobe [Body Part, Organ, or Organ Component]
   760   C1428707:Lobe [Gene or Genome]
   760   C2362314:Temporal [Temporal Concept]
   760   C3539671:Lobe [Gene or Genome]

Phrase: "the mutated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "the major 4R tau component."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0449432:Component [Manufactured Object]
   804   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.74: The sarkosyl-insoluble fraction from the relatively unaffected cerebellum of P301L patients did not show the presence of hyperphosphorylated tau protein, as expected (data not shown). 

Phrase: "The sarkosyl-insoluble fraction from the relatively unaffected cerebellum of P301L patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C1264633:Fraction of [Quantitative Concept]
           Fraction
   736   C1554103:Fraction [Idea or Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the presence of hyperphosphorylated tau protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.75: Sarkosyl-soluble tau from the frontal, temporal cortex and cerebellum of the three P301L patients, stained with the H-7 antibody, showed a pattern similar to that of the control case (Fig. 5): six bands aligned with the six isoforms from the recombinant tau. 

Phrase: "Sarkosyl-soluble tau from the frontal, temporal cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1720655:Tau [Intellectual Product]
   744   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "cerebellum of the three P301L patients,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   753   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   753   C1707522:Cerebellum [Tissue]

Phrase: "stained with the H-7 antibody,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   783   C0369286:H not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "similar to that of the control case"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ":"

Phrase: "six bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "aligned with the six isoforms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205452:Six [Quantitative Concept]
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   760   C1706765:Aligned [Quantitative Concept]
   726 E C2369992:Align [Pharmacologic Substance]

Phrase: "from the recombinant tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]
Processing 00000000.tx.76: Staining with tau-P301 and tau-P301L antibodies (Fig. 6AC) resolved this sarkosyl-soluble dephosphorylated tau into two major bands corresponding to 4R and 4R + 29 amino acids isoforms. 

Phrase: "Staining with tau-P301"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "tau-P301L antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 6AC"

Phrase: ")"

Phrase: "resolved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]

Phrase: "this sarkosyl-soluble dephosphorylated tau into two major bands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]

Phrase: "corresponding to 4R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205341:Repeat [Functional Concept]
   770   C1547730:Repeat [Temporal Concept]
   770   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "4R + 29 amino acids isoforms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.77: A quantitative analysis was performed to compare the 3R:4R ratio in the soluble fractions among the P301L cases and the age-matched control. 

Phrase: "A quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the 3R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: ":"

Phrase: "4R ratio in the soluble fractions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "among the P301L cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "the age-matched control."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0001779:Age [Organism Attribute]
   827   C0150103:matched [Research Activity]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1708943:Matched [Qualitative Concept]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.78: No significant differences were observed in all cases, the ratio was 1 in the frontal cortex. 

Phrase: "No significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed in all cases,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "1 in the frontal cortex."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0205123:Frontal [Spatial Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]
Processing 00000000.tx.79: A single patient showed a decrease of 20% for 4R tau, similar to what has been described previously (16). 

Phrase: "A single patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a decrease of 20%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "for 4R tau,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "similar to what"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.80: The cerebellum of the FTDP-17 cases and the control contained more 4R tau than 3R, again in agreement with Hong et al. 

Phrase: "The cerebellum of the FTDP-17 cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   748   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   748   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "more 4R tau than 3R,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C2362079:TAU 3 [Immunologic Factor]
   774   C2362080:TAU 4 [Immunologic Factor]
   748   C0205341:Repeat [Functional Concept]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "again in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with Hong et al."
Processing 00000000.tx.81: (16). 

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.82: View larger version (58K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(58K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.83: Quantitative immunoblot of sarkosyl-soluble tau from frontal cortex of one control and three P301L patients and cerebellum from two P301L patients and one control. 

Phrase: "Quantitative immunoblot of sarkosyl-soluble tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "from frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of one control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "three P301L patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "cerebellum from two P301L patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   760   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   760   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "one control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.84: Sarkosyl-soluble tau was dephosphorylated and stained with the H-7 antibody. 

Phrase: "Sarkosyl-soluble tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "dephosphorylated"

Phrase: "and"

Phrase: "stained with the H-7 antibody."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   783   C0369286:H not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.85: Six bands were obtained that aligned with the six isoforms of the recombinant tau.  

Phrase: "Six bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "that"

Phrase: "aligned with the six isoforms of the recombinant tau."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0205452:Six [Quantitative Concept]
   742   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   742   C1514798:recombinant [Organism]
   742   C1706765:Aligned [Quantitative Concept]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   708 E C2369992:Align [Pharmacologic Substance]
Processing 00000000.tx.86: View larger version (59K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.87: Quantitative immunoblot of sarkosyl-soluble tau from the frontal cortex (A), the temporal cortex (B) and the cerebellum (C) of one control case and three P301L patients, using the tau-P301 and tau-P301L antibodies after alkaline phosphatase treatment. 

Phrase: "Quantitative immunoblot of sarkosyl-soluble tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "from the frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "the temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "the cerebellum (C) of one control case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   753   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   753   C1707522:Cerebellum [Tissue]

Phrase: "and"

Phrase: "three P301L patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the tau-P301"

Phrase: "and"

Phrase: "tau-P301L antibodies after alkaline phosphatase treatment."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.88: The three isoforms containing 4R + 0, + 29 and + 58 amino acids, respectively, aligned with the corresponding isoforms of the recombinant tau. 

Phrase: "The three isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "4R + 0,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "+ 29"

Phrase: "and +"

Phrase: "58 amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "respectively,"

Phrase: "aligned with the corresponding isoforms of the recombinant tau."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   742   C1514798:recombinant [Organism]
   742   C1706765:Aligned [Quantitative Concept]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
   708 E C2369992:Align [Pharmacologic Substance]
Processing 00000000.tx.89: The two intermediate cleavage products, <45 kDa, are indicated by arrows. 

Phrase: "The two intermediate cleavage products,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0010813:cleavage [Cell Function]
   812   C0596311:Cleavage [Phenomenon or Process]
   812   C1330957:cleavage [Cell Function]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "<45 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.90: (D). 

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.91: Ratio between normal 4R and mutated P301L protein in the soluble fraction from frontal cortex, temporal cortex and cerebellum. 

Phrase: "Ratio between normal 4R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "mutated P301L protein in the soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from frontal cortex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "cerebellum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.92: The amount of mutated P301L tau in the soluble fraction of frontal cortex in P301L1 patient was below detection level.  

Phrase: "The amount of mutated P301L tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "in the soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "of frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "in P301L1 patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "was below detection level."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1421478:WAS [Gene or Genome]
   770   C1511790:Detection [Therapeutic or Preventive Procedure]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.93: The same experiment was repeated to determine the ratio between mutated P301L and normal 4R tau (Fig. 6D) and a striking decrease of mutated P301L protein was observed in the soluble fraction from the frontal cortex where the amount of the normal 4R tau was on average 5-fold higher than the mutated tau. 

Phrase: "The same experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the ratio between mutated P301L"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "normal 4R tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205341:Repeat [Functional Concept]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "(Fig. 6D"

Phrase: ")"

Phrase: "and"

Phrase: "a striking decrease of mutated P301L protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed in the soluble fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "from the frontal cortex where"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C0205123:Frontal [Spatial Concept]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "the amount of the normal 4R tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "was on average 5-fold"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332462:Fold [Spatial Concept]
   760   C1421478:WAS [Gene or Genome]
   760   C1510992:Average [Quantitative Concept]
   760   C1880834:FOLD [Phenomenon or Process]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "higher than the mutated tau."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.94: In the temporal cortex the difference was less strong, showing a 2- to 5-fold decrease of mutated P301L tau compared with the normal 4R. 

Phrase: "In the temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "the difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "less strong,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442821:Strong [Qualitative Concept]
   789 E C0237897:Strength [Quantitative Concept]
   789 E C0808080:Strength [Idea or Concept]
   789 E C1705922:Strength [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 5-fold decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392756:Decrease [Qualitative Concept]
   827   C0547047:Decrease [Quantitative Concept]

Phrase: "of mutated P301L tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "compared with the normal 4R."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205307:Normal [Qualitative Concept]
   753   C0205341:Repeat [Functional Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1547730:Repeat [Temporal Concept]
   753   C1705914:Repeat [Conceptual Entity]
   753   C1707455:Compared [Activity]
   753   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.95: In the non-affected area of the cerebellum a 2-fold decrease was observed for the P301L protein with respect to the normal 4R tau. 

Phrase: "In the non-affected area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1879646:Affected Area [Finding]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: "of the cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "a 2-fold decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392756:Decrease [Qualitative Concept]
   827   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed for the P301L protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1441672:Observed [Functional Concept]

Phrase: "with respect to the normal 4R tau."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205341:Repeat [Functional Concept]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
Processing 00000000.tx.96: Below 45 kDa, two bands were detected with both the tau-P301 and tau-P301L antibodies but their intensity was significantly stronger with the tau-P301L antibody. 

Phrase: "Below 45 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "two bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "detected with both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the tau-P301"

Phrase: "and"

Phrase: "tau-P301L antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "but"

Phrase: "their intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "significantly stronger with the tau-P301L antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0442821:Strong [Qualitative Concept]
Processing 00000000.tx.97: Since we carefully matched the total amount of protein loaded on the gel for each sample and we have showed that both antibodies have similar strength, it is unlikely that the differences in the intensity of the two bands seen with the two antibodies are caused by proteolysis in the experimental procedure, suggesting therefore an alteration of the proteolytic processing of the mutated P301L protein compared with the normal protein. 

Phrase: "Since"

Phrase: "we carefully"

Phrase: "matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:matched [Research Activity]
  1000   C1708943:Matched [Qualitative Concept]

Phrase: "the total amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "loaded on the gel"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "for each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "we"

Phrase: "have"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "have"

Phrase: "similar strength,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0237897:Strength [Quantitative Concept]
   861   C0808080:Strength [Idea or Concept]
   861   C1705922:Strength [Qualitative Concept]
   789 E C0442821:Strong [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the differences in the intensity of the two bands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "seen with the two antibodies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205397:Seen [Qualitative Concept]
   760   C0205448:Two [Quantitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "are"

Phrase: "caused by proteolysis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0597304:Proteolysis [Molecular Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   718 E C1947941:proteolytic [Enzyme]

Phrase: "in the experimental procedure,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "therefore"

Phrase: "an alteration of the proteolytic processing of the mutated P301L protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1515926:Alteration [Idea or Concept]

Phrase: "compared with the normal protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0860902:normal protein [Finding]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1707455:Compared [Activity]
   760   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.98: Therefore, we performed pulsechase experiments and determined the half-life of normal 4R tau and its mutant P301L counterpart in transiently transfected COS cells. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "pulsechase experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "determined"

Phrase: "the half-life of normal 4R tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018517:Half-Life [Temporal Concept]
   744   C0376558:Life [Idea or Concept]
   744   C2825407:Half [Quantitative Concept]

Phrase: "and"

Phrase: "its mutant P301L counterpart in transiently transfected COS cells."
Processing 00000000.tx.99: Newly synthesized tau proteins were harvested at different time points (0, 6, 10 and 22 h) and immunoprecipitated with H-7 monoclonal antibody. 

Phrase: "Newly synthesized tau proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "were"

Phrase: "harvested at different time points"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   773   C2348792:Time Point [Temporal Concept]
   762   C1442103:Time Difference [Temporal Concept]
   762   C1547049:*Time Difference [Quantitative Concept]
   760   C0040223:Time [Temporal Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1512335:Harvest [Health Care Activity]
   726   C1552961:Point [Quantitative Concept]
   726   C2347617:point [Quantitative Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "(0,"

Phrase: "6,"

Phrase: "10"

Phrase: "and"

Phrase: "22 h)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "immunoprecipitated with H-7 monoclonal antibody."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   783   C0369286:H not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C0746619:monoclonal [Finding]
   719   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.100: After 22 h only little amounts of normal 4R (4.9  2.4%) and P301L (6.6  3%) tau proteins were present. 

Phrase: "After 22 h only little amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1265611:amounts [Quantitative Concept]

Phrase: "of normal 4R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]

Phrase: "(4.9  2.4%"

Phrase: ")"

Phrase: "and"

Phrase: "P301L"

Phrase: "(6.6  3%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1630409:6/3 [Finding]
   901   C0442750:6/6 [Finding]

Phrase: ")"

Phrase: "tau proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "were"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.101: However, after 10 h of chase a significant delay in the degradation of P301L tau (40  13%) compared with the normal 4R (67  1.75%) was observed (Fig. 7). 

Phrase: "However,"

Phrase: "after"

Phrase: "10 h of chase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "a significant delay in the degradation of P301L tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205421:Delay [Temporal Concept]

Phrase: "(40  13%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "compared with the normal 4R"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205307:Normal [Qualitative Concept]
   753   C0205341:Repeat [Functional Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1547730:Repeat [Temporal Concept]
   753   C1705914:Repeat [Conceptual Entity]
   753   C1707455:Compared [Activity]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "(67  1.75%"

Phrase: ")"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.102: View larger version (14K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.103: Pulsechase experiments on COS cells transfected with normal 4R and P301L tau. 

Phrase: "Pulsechase experiments on COS cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "transfected with normal 4R"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205307:Normal [Qualitative Concept]
   760   C0205341:Repeat [Functional Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1547730:Repeat [Temporal Concept]
   760   C1705914:Repeat [Conceptual Entity]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "P301L tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]
Processing 00000000.tx.104: Cells labeled with [35S]methionine were incubated in unlabeled chase medium for intervals up to 22 h and harvested at time points indicated. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated in unlabeled chase medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "for intervals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1272706:intervals [Temporal Concept]
   966 E C1552654:Interval [Idea or Concept]
   966 E C1552713:Interval [Intellectual Product]

Phrase: "up to 22 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "harvested at time points"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   799   C2348792:Time Point [Temporal Concept]
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   737   C1512335:Harvest [Health Care Activity]
   737   C1552961:Point [Quantitative Concept]
   737   C2347617:point [Quantitative Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.105: NT, non-transfected COS cells used as negative control. 

Phrase: "NT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332126:NT [Qualitative Concept]
  1000   C1449832:NT [Diagnostic Procedure]

Phrase: "non-transfected COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0376702:COS Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "used as negative control."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   833   C1639518:% negative control [Quantitative Concept]
   833   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1513916:Negative [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.106: The amount of residual 35S-labeled 4R and P301L tau proteins in COS cells are expressed as percentage of the label measured immediately after pulse labeling (0 h).   

Phrase: "The amount of residual 35S-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "4R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: "and"

Phrase: "P301L tau proteins in COS cells"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C1421563:protein tau [Gene or Genome]
   756 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "are"

Phrase: "expressed as percentage of the label"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0181496:Label [Manufactured Object]
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   753   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "pulse labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(0 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.107: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The mutations found in the gene for the microtubule-associated protein tau in FTDP-17 patients have provided us with new opportunities to study the role of tau protein in neurodegenerative disorders characterized by tau pathology. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "found in the gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "for the microtubule-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in FTDP-17 patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0338451:FTDP-17 [Disease or Syndrome]
   734   C1446659:FTDP-17 [Gene or Genome]
   734   C2697954:FTDP-17 [Gene or Genome]

Phrase: "have"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "us with new opportunities to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205314:New [Temporal Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the role of tau protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "characterized by tau pathology."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]
   770   C1720655:Tau [Intellectual Product]
   770   C1880022:Characterized [Activity]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.108: Several in vitro studies have demonstrated that most missense mutations result in impaired binding and microtubule polymerization capacities compared with the normal 4R protein (1517,23,24), suggesting a possible role for mutated tau protein in the neurodegeneration process through a progressive disruption of microtubule function and stability. 

Phrase: "Several in vitro studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C0681828:in vitro study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "most missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "result in impaired binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0221099:Impaired [Functional Concept]
   770   C0243122:binding [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "microtubule polymerization capacities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1516240:Capacity [Quantitative Concept]
   734   C1156032:Microtubule Polymerization [Cell Function]

Phrase: "compared with the normal 4R protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0860902:normal protein [Finding]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205307:Normal [Qualitative Concept]
   748   C0205341:Repeat [Functional Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C1547730:Repeat [Temporal Concept]
   748   C1705914:Repeat [Conceptual Entity]
   748   C1707455:Compared [Activity]
   748   C2347086:% Normal [Quantitative Concept]

Phrase: "(1517,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a possible role for mutated tau protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the neurodegeneration process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "through a progressive disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "of microtubule function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.109: However, in a recent study (24) cells transiently transfected with wild-type or mutated tau constructs could not be distinguished in terms of tau-decorated microtubule networks and bundles, suggesting that mutations do not have a large and immediate effect on the interactions between tau and microtubules. 

Phrase: "However,"

Phrase: "in a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(24"

Phrase: ")"

Phrase: "cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutated tau constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "distinguished in terms of tau-decorated microtubule networks"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0026046:Micro-tubule [Cell Component]
   744   C1720655:Tau [Intellectual Product]
   744   C1882071:networks [Conceptual Entity]
   744   C1947974:Tau [Research Activity]
   711 E C1513822:Network [Professional or Occupational Group]
   711   C1515273:Term [Temporal Concept]
   711   C1705313:Term [Idea or Concept]
   711 E C1705739:Network [Manufactured Object]
   711   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "bundles,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a large"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549177:Large [Quantitative Concept]

Phrase: "and"

Phrase: "immediate effect on the interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "between tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "microtubules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]
Processing 00000000.tx.110: More recently, in vitro studies demonstrated that most missense mutations also increase taus potential for the formation of fibrils, both at the nucleation and the elongation phases and this gain-of-function of mutant tau might explain the observed aggregation of tau protein in brain. 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "in vitro studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0681828:in vitro study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "most missense mutations also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0599155:Mutations, Missense [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "taus potential for the formation of fibrils,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "both at the nucleation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "the elongation phases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0585064:Phases [Temporal Concept]
   861   C1067936:Phasis [Eukaryote]
   827 E C0205390:Phase [Temporal Concept]

Phrase: "and"

Phrase: "this gain-of-function of mutant tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "might"

Phrase: "explain"

Phrase: "the observed aggregation of tau protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "in brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.111: For a better understanding of the role of the mutated protein in the pathogenesis of the disease we studied the localization and levels of the P301L and normal 4R tau proteins in brain material from patients with P301L mutation using rabbit polyclonal antibodies specifically directed against the P301L mutation and its normal 4R counterpart. 

Phrase: "For a better understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162340:Understanding [Mental Process]

Phrase: "of the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "of the mutated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "levels of the P301L"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "normal 4R tau proteins in brain material"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0860902:normal protein [Finding]
   750 E C1421563:protein tau [Gene or Genome]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with P301L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rabbit polyclonal antibodies specifically"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the P301L mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "its normal 4R counterpart."
Processing 00000000.tx.112: Our immunohistochemistry experiments clearly show the presence of both mutated and normal 4R tau protein in the perinuclear deposits in the affected areas of frontal and temporal cortex and hippocampal formations. 

Phrase: "Our immunohistochemistry experiments clearly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the presence of both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "and"

Phrase: "normal 4R tau protein in the perinuclear deposits"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   764   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   762   C0860902:normal protein [Finding]
   762 E C1421563:protein tau [Gene or Genome]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the affected areas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1879646:Affected Area [Finding]
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "of frontal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205123:Frontal [Spatial Concept]

Phrase: "and"

Phrase: "temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampal formations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175202:Hippocampal Formations [Body Part, Organ, or Organ Component]
   861   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   861   C0439634:Formations [Spatial Concept]
   827 E C0220781:formation [Biologic Function]
   827 E C1522492:Formation [Functional Concept]
Processing 00000000.tx.113: No clear differences were observed in the cellular localization of the mutated P301L protein versus the normal 4R tau. 

Phrase: "No clear differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed in the cellular localization of the mutated P301L protein"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   775   C2612729:cellular protein localisation [Cell Function]
   760   C1660642:cellular localisation [Cell Function]
   757   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0597704:protein localisation [Cell Function]
   757   C1159772:Protein Localization [Cell Function]
   739   C0007634:Cellular [Cell]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0178539:Cellular [Functional Concept]
   739   C0475264:Localisation [Functional Concept]
   739   C1441672:Observed [Functional Concept]
   739   C1705285:Mutated [Cell or Molecular Dysfunction]
   739   C1744691:localisation [Biologic Function]
   706 E C1513776:Mutate [Genetic Function]

Phrase: "versus"

Phrase: "the normal 4R tau."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205341:Repeat [Functional Concept]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
Processing 00000000.tx.114: The diffuse staining seen occasionally in the axons with both antibodies, suggests that both normal and mutated protein are present in the axons. 

Phrase: "The diffuse staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "occasionally in the axons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0004461:Axons [Cell Component]
   770   C1998882:Occasionally [Temporal Concept]

Phrase: "with both antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "mutated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "present in the axons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.115: This finding suggests that the P301L mutation does not result in the absence of mutated protein from the axon, which can be explained by the observation that tau mRNA is selectively translated in the axons of neurons. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the P301L mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in the absence of mutated protein"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332197:absence [Quantitative Concept]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1705285:Mutated [Cell or Molecular Dysfunction]
   748   C2825142:Result [Finding]
   714 E C1513776:Mutate [Genetic Function]

Phrase: "from the axon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axon [Cell Component]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "explained by the observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that tau mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "selectively"

Phrase: "translated in the axons of neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0004461:Axons [Cell Component]
   753   C0027882:Neurons [Cell]
   753   C0040710:translated [Occupational Activity]
Processing 00000000.tx.116: The fact that the axonal staining is seen only in one patient might reflect the limits of using these antibodies on paraffin-embedded material. 

Phrase: "The fact"

Phrase: "that"

Phrase: "the axonal staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "only in one patient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:*^patient [Patient or Disabled Group]
   770   C0205171:Only [Quantitative Concept]
   770   C0205447:One [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the limits of"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0439801:limits [Functional Concept]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]
   706 E C3542948:Limited [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these antibodies on paraffin-embedded material."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.117: In our biochemical experiments, we show that the aggregates, in patients with the P301L mutation, mainly consist of mutant 4R tau and that only small amounts of normal 4R and 3R proteins are present. 

Phrase: "In our biochemical experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with the P301L mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "mainly"

Phrase: "consist of mutant 4R tau"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C2362080:TAU 4 [Immunologic Factor]
   753   C0205341:Repeat [Functional Concept]
   753   C0332529:CONSIST [Qualitative Concept]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1547730:Repeat [Temporal Concept]
   753   C1705914:Repeat [Conceptual Entity]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "that only small amounts of normal 4R"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "3R proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.118: This preferential incorporation of mutated protein is, however, not reflected in the overall ratio of 3R:4R tau protein in the soluble fraction of frontal and temporal lobe and cerebellum. 

Phrase: "This preferential incorporation of mutated protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243126:incorporation [Functional Concept]

Phrase: "is"

Phrase: ","

Phrase: "however,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reflected in the overall ratio of 3R"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205341:Repeat [Functional Concept]
   744   C0282416:Overall [Intellectual Product]
   744   C0456603:Ratio [Quantitative Concept]
   744   C0558058:reflected [Mental Process]
   744   C1547037:Ratio [Intellectual Product]
   744   C1547730:Repeat [Temporal Concept]
   744   C1561607:Overall [Qualitative Concept]
   744   C1705914:Repeat [Conceptual Entity]

Phrase: ":"

Phrase: "4R tau protein in the soluble fraction of frontal"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   757 E C1421563:protein tau [Gene or Genome]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "temporal lobe"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0039485:Temporal Lobe [Body Part, Organ, or Organ Component]
  1000   C1268978:Temporal lobe [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C0796494:lobe [Body Part, Organ, or Organ Component]
   861   C1428707:Lobe [Gene or Genome]
   861   C2362314:Temporal [Temporal Concept]
   861   C3539671:Lobe [Gene or Genome]
   789 E C1522010:Lobar [Qualitative Concept]

Phrase: "and"

Phrase: "cerebellum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.119: The 3R:4R tau ratio remained unchanged in two of the P301L patients with respect to the age-matched control and one patient showed only a 20% decrease of 4R tau. 

Phrase: "The 3R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205341:Repeat [Functional Concept]
   861   C1547730:Repeat [Temporal Concept]
   861   C1705914:Repeat [Conceptual Entity]

Phrase: ":"

Phrase: "4R tau ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "remained"

Phrase: "unchanged in two of the P301L patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0442739:Unchanged [Finding]
   748   C2346711:Unchanged [Qualitative Concept]

Phrase: "with respect to the age-matched control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0001779:Age [Organism Attribute]
   827   C0150103:matched [Research Activity]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1708943:Matched [Qualitative Concept]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "one patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a 20% decrease of 4R tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.120: FTDP-17 is an autosomal dominant disorder and, therefore, the P301L protein in patients is produced by a single allele. 

Phrase: "FTDP-17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0338451:FTDP-17 [Disease or Syndrome]
  1000   C1446659:FTDP-17 [Gene or Genome]
  1000   C2697954:FTDP-17 [Gene or Genome]

Phrase: "is"

Phrase: "an autosomal dominant disorder"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012634:Disorder [Disease or Syndrome]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "and"

Phrase: ","

Phrase: "therefore,"

Phrase: "the P301L protein in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "produced by a single allele."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002085:Allele [Gene or Genome]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
Processing 00000000.tx.121: Assuming that the normal ratio of 3R:4R tau is 1, a 2-fold change in ratio of 3R:4R protein would be expected if all P301L proteins were effectively incorporated in aggregates or selectively degraded. 

Phrase: "Assuming"

Phrase: "that"

Phrase: "the normal ratio of 3R"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "4R tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "a 2-fold change in ratio of 3R"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1880833:Fold Change [Quantitative Concept]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "4R protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "if"

Phrase: "all P301L proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "effectively"

Phrase: "incorporated in aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205418:aggregates [Qualitative Concept]

Phrase: "or"

Phrase: "selectively"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.122: The fact that this change in 3R:4R ratio is not observed suggests that upregulation of the expression level of the normal 4R tau isoform might compensate for the depletion of mutant 4R tau. 

Phrase: "The fact"

Phrase: "that"

Phrase: "this change in 3R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "4R ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that upregulation of the expression level of the normal 4R tau isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0041904:Up-Regulation [Cell Function,Molecular Function]
   735   C0162493:Up-Regulation [Genetic Function]

Phrase: "might"

Phrase: "compensate for the depletion of mutant 4R tau."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   762   C2362080:TAU 4 [Immunologic Factor]
   742   C0205341:Repeat [Functional Concept]
   742   C0205432:compensate [Qualitative Concept]
   742   C0333668:Depletion [Functional Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1547730:Repeat [Temporal Concept]
   742   C1705914:Repeat [Conceptual Entity]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]
Processing 00000000.tx.123: However, to determine whether our finding is a general finding for the P301L mutation more patient material should be investigated. 

Phrase: "However,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "our finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "a general finding for the P301L mutation more patient material"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0037088:Finding [Sign or Symptom]
   739   C0243095:Finding [Finding]
   739   C2825141:Finding [Finding]

Phrase: "should"

Phrase: "be"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.124: Using the tau-P301L and tau-P301 antibodies, we demonstrate that in the soluble fraction the 4R tau mainly consists of normal protein and the P301L protein is almost not present. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the tau-P301L"

Phrase: "and"

Phrase: "tau-P301 antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that in the soluble fraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "the 4R tau mainly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205341:Repeat [Functional Concept]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "consists of normal protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0860902:normal protein [Finding]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205307:Normal [Qualitative Concept]
   770   C0332529:CONSIST [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "the P301L protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "almost"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.125: The most notable depletion of the mutant P301L protein with respect to the normal 4R protein was observed in the frontal lobe (5-fold) and temporal lobe (on average 3-fold), the most affected areas of the brain. 

Phrase: "The most notable depletion of the mutant P301L protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0333668:Depletion [Functional Concept]

Phrase: "with respect to the normal 4R protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0860902:normal protein [Finding]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "observed in the frontal lobe"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0016733:frontal lobe [Body Part, Organ, or Organ Component]
   806   C1268977:Frontal lobe [Body Part, Organ, or Organ Component]
   760   C0205123:Frontal [Spatial Concept]
   760   C0796494:lobe [Body Part, Organ, or Organ Component]
   760   C1428707:Lobe [Gene or Genome]
   760   C1441672:Observed [Functional Concept]
   760   C3539671:Lobe [Gene or Genome]

Phrase: "(5-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "temporal lobe"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0039485:Temporal Lobe [Body Part, Organ, or Organ Component]
  1000   C1268978:Temporal lobe [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C0796494:lobe [Body Part, Organ, or Organ Component]
   861   C1428707:Lobe [Gene or Genome]
   861   C2362314:Temporal [Temporal Concept]
   861   C3539671:Lobe [Gene or Genome]
   789 E C1522010:Lobar [Qualitative Concept]

Phrase: "("

Phrase: "on average 3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "the most affected areas of the brain."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1879646:Affected Area [Finding]
   748   C0205146:areas [Spatial Concept]
   714 E C0017446:Area [Geographic Area]
Processing 00000000.tx.126: In cerebellum, where no tau aggregates were observed, the depletion of mutant protein was the smallest (2-fold). 

Phrase: "In cerebellum,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "where"

Phrase: "no tau aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "the depletion of mutant protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333668:Depletion [Functional Concept]

Phrase: "was"

Phrase: "the smallest"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2700395:Smallest [Quantitative Concept]
   966 E C0700321:Small [Quantitative Concept]

Phrase: "(2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.127: The observation that P301L protein is selectively trapped in the insoluble deposits of the frontal and temporal cortices and the finding that tau protein with the P301L mutation has a high potential to form fibrils in vitro, provides an attractive explanation for the formation of the characteristic tau aggregates in brains of patients. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that P301L protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "selectively"

Phrase: "trapped in the insoluble deposits of the frontal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0184047:Trapped [Medical Device]
   744   C0205123:Frontal [Spatial Concept]
   744   C0333562:Deposits [Functional Concept]

Phrase: "and"

Phrase: "temporal cortices"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C2362314:Temporal [Temporal Concept]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that tau protein with the P301L mutation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   774 E C1421563:protein tau [Gene or Genome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "has"

Phrase: "a high potential to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   827   C3245505:Potential [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "an attractive explanation for the formation of the characteristic tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0681841:Explanation [Intellectual Product]

Phrase: "aggregates in brains of patients."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0205418:Aggregate [Qualitative Concept]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.128: However, we then would expect that during the period of 4060 years before the death of the patient the selective trapping of the mutated protein from the soluble tau fraction into insoluble aggregates would lead to extensive deposit formation in all neurons. 

Phrase: "However,"

Phrase: "we then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "would"

Phrase: "expect"

Phrase: "that during the period of 4060 years"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0439234:years [Temporal Concept]
   748   C0439531:/period [Temporal Concept]
   748   C1948053:Period [Temporal Concept]
   714 E C0439508:/year [Temporal Concept]

Phrase: "before the death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "of the patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "the selective trapping of the mutated protein"

Phrase: "from the soluble tau fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "into insoluble aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "would"

Phrase: "lead to extensive deposit formation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205231:Extensive [Qualitative Concept]
   760   C0220781:formation [Biologic Function]
   760   C0333562:Deposit [Functional Concept]
   760   C0439634:formation [Spatial Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522492:Formation [Functional Concept]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in all neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.129: Instead, insoluble tau aggregates are visible only in a small subset of neurons and in specific areas of the brain. 

Phrase: "Instead,"

Phrase: "insoluble tau aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "are"

Phrase: "visible only in a small subset of neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   750   C0228075:Small neuron [Cell]
   744   C0027882:Neurons [Cell]
   744   C0205171:Only [Quantitative Concept]
   744   C0205379:Visible [Qualitative Concept]
   744   C0700321:Small [Quantitative Concept]
   744   C1515021:Subset [Classification]
   744   C1720467:Only [Intellectual Product]

Phrase: "and in specific areas of the brain."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0205146:areas [Spatial Concept]
   748   C0205369:Specific [Qualitative Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1515981:And [Idea or Concept]
   748   C1552740:specific [Intellectual Product]
   714 E C0017446:Area [Geographic Area]
Processing 00000000.tx.130: So other factors must be involved as well. 

Phrase: "So"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "must"

Phrase: "be"

Phrase: "involved as well."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205170:Well [Qualitative Concept]
   790   C1314939:Involved [Functional Concept]
   790   C3146287:Well [Manufactured Object]
Processing 00000000.tx.131: Our finding that the immunoblots of the soluble tau material show two bands of <45 kDa might point towards an alternative explanation. 

Phrase: "Our"

Phrase: "finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the immunoblots of the soluble tau material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "two bands of <45 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]

Phrase: "might"

Phrase: "point towards an alternative explanation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0681841:Explanation [Intellectual Product]
   760   C1523987:Alternative [Conceptual Entity]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
Processing 00000000.tx.132: These two bands are strongly stained with the antibody specific for the point mutation and only weakly with the tau-P301 that recognizes the normal 4R. 

Phrase: "These two bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "are"

Phrase: "strongly"

Phrase: "stained with the antibody specific"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   797   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   760   C2986582:Stained [Qualitative Concept]
   735 E C0003264:Antibody Specificity [Molecular Function]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "for the point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "only weakly with the tau-P301"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205171:Only [Quantitative Concept]
   753   C1720467:Only [Intellectual Product]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "that"

Phrase: "recognizes"

Phrase: "the normal 4R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205341:Repeat [Functional Concept]
   827   C1547730:Repeat [Temporal Concept]
   827   C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.133: They are present in the frontal and temporal cortex as well as in the cerebellum, an area that does not show any deposits. 

Phrase: "They"

Phrase: "are"

Phrase: "present in the frontal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "temporal cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2362314:Temporal [Temporal Concept]
   861   C2700441:Cortex [Plant]

Phrase: "as well as in the cerebellum,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   753   C0205170:Well [Qualitative Concept]
   753   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   753   C1707522:Cerebellum [Tissue]
   753   C3146287:Well [Manufactured Object]

Phrase: "an area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposits [Functional Concept]
Processing 00000000.tx.134: These bands may be intermediate fragments generated during the normal proteolysis of the mutated protein. 

Phrase: "These bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "may"

Phrase: "be"

Phrase: "intermediate fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "generated during the normal proteolysis of the mutated protein."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0860902:normal protein [Finding]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205307:Normal [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C0597304:Proteolysis [Molecular Function]
   742   C1705285:Mutated [Cell or Molecular Dysfunction]
   742   C2347086:% Normal [Quantitative Concept]
   742   C3146294:Generated [Activity]
   708 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.135: Tau is sensitive to calpain and caspase proteolysis in neurons (28), resulting in the generation of multiple fragments, the major fragment being 42 kDa in size. 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "sensitive to calpain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332324:Sensitive to [Functional Concept]
           Sensitive
   790   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "caspase proteolysis in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "resulting in the generation of multiple fragments,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   778   C0332294:Resulting in [Functional Concept]
   748   C0079411:Generation [Temporal Concept]
   748   C0332255:fragments [Functional Concept]
   748   C0439064:Multiple [Quantitative Concept]
   748   C0486805:Fragments [Body Substance]
   748   C0678226:resulting [Functional Concept]
   748   C3146294:Generation [Activity]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C1708096:Fragment [Qualitative Concept]
   714 E C2825142:Result [Finding]

Phrase: "the major fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "being"

Phrase: "42 kDa in size."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.136: The relative increase in mutant tau positive cleavage products might suggest that the mutant protein is more resistant to further calpain degradation with respect to the normal protein and this resistance might cause accumulation of intermediate proteolysis products. 

Phrase: "The relative increase in mutant tau positive cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "might"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "more resistant to further calpain degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332325:Resistant to [Functional Concept]
           Resistant
   753   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "with respect to the normal protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860902:normal protein [Finding]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "this resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0237834:Resistance [Mental Process]
  1000   C1514892:Resistance [Physiologic Function]
   928 E C0332325:Resistant [Functional Concept]
   928 E C1550464:resistent [Idea or Concept]
   928 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "might"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "accumulation of intermediate proteolysis products."
Processing 00000000.tx.137: Yen et al. 

Phrase: "Yen et al."
Processing 00000000.tx.138: (29), using an invitro assay, indeed reported that the P301L protein is more resistant to calpain degradation than the normal 4R tau. 

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an invitro assay,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1515653:In Vitro Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "indeed"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the P301L protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "more resistant to calpain degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "than the normal 4R tau."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205341:Repeat [Functional Concept]
   812   C1547730:Repeat [Temporal Concept]
   812   C1705914:Repeat [Conceptual Entity]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
Processing 00000000.tx.139: Our pulsechase experiment showed that there is a delay in the degradation of mutated P301L protein in COS cells. 

Phrase: "Our pulsechase experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that there"

Phrase: "is"

Phrase: "a delay in the degradation of mutated P301L protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205421:Delay [Temporal Concept]

Phrase: "in COS cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.140: Although our data are based on overexpression studies, the finding that there is a delay in the degradation of the mutated P301L tau protein compared with the normal 4R under the same experimental conditions suggests a potential mechanism by which the mutated protein accumulates in the cytoplasm at higher concentrations. 

Phrase: "Although"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "based on overexpression studies,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0947630:studies [Laboratory Procedure]
   770   C1514559:Overexpression [Genetic Function]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C0557651:Study [Manufactured Object]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C2603343:Study [Research Activity]

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that there"

Phrase: "is"

Phrase: "a delay in the degradation of the mutated P301L tau protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0205421:Delay [Temporal Concept]

Phrase: "compared with the normal 4R"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205307:Normal [Qualitative Concept]
   753   C0205341:Repeat [Functional Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1547730:Repeat [Temporal Concept]
   753   C1705914:Repeat [Conceptual Entity]
   753   C1707455:Compared [Activity]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "under the same experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a potential mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "the mutated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accumulates in the cytoplasm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0010834:Cytoplasm [Cell Component]

Phrase: "at higher concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.141: It is tempting to speculate that due to the presence of mutated protein and the accumulation of intermediate cleavage products, cells are more vulnerable to stress agents associated with aging, which in time might trigger alterations and modifications in the proteolytic degradation of the mutated tau versus the normal protein. 

Phrase: "It"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "speculate"

Phrase: "that due to the presence of mutated protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0678226:Due to [Functional Concept]
           due
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1705285:Mutated [Cell or Molecular Dysfunction]
   744   C3146286:Due [Idea or Concept]
   711 E C1513776:Mutate [Genetic Function]

Phrase: "and"

Phrase: "the accumulation of intermediate cleavage products,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "more vulnerable to stress agents"

Phrase: "associated with aging,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0001811:Ageing [Organism Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "which in time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "might"

Phrase: "trigger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "modifications in the proteolytic degradation of the mutated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0392747:Modification [Functional Concept]
   708   C1554963:modification [Qualitative Concept]

Phrase: "versus"

Phrase: "the normal protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860902:normal protein [Finding]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.142: Over time the combined effects of reduced microtubule assemblage and accelerated filament formation characteristic of the P301L mutation might lead to an increase of unbound cytosolic mutated P301L in the form of aggregates. 

Phrase: "Over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "the combined effects of reduced microtubule assemblage"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "accelerated filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "characteristic of the P301L mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1521970:Characteristic [Qualitative Concept]

Phrase: "might"

Phrase: "lead to an increase of unbound cytosolic mutated P301L"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0442805:Increase [Functional Concept]
   742   C1383501:Cytosolic [Cell Component]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1705285:Mutated [Cell or Molecular Dysfunction]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]
   708 E C1513776:Mutate [Genetic Function]

Phrase: "in the form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "of aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]
Processing 00000000.tx.143: The question arises of whether for FTDP-17, as for many other neurodegenerative disorders such as AD, prion diseases, ALS and the polyglutamine repeat disorders, the aggregates are the pathogenic agents or simply markers of the cells demise. 

Phrase: "The question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "arises of"

Phrase: "whether for FTDP-17,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0338451:FTDP-17 [Disease or Syndrome]
   833   C1446659:FTDP-17 [Gene or Genome]
   833   C2697954:FTDP-17 [Gene or Genome]

Phrase: "as for many"

Phrase: "other neurodegenerative disorders such as AD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   778   C1522560:Neurodegenerative Disorders [Functional Concept]
   757   C0012634:disease/disorder [Disease or Syndrome]
           Disorders

Phrase: "prion diseases,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0162534:Prion Diseases [Disease or Syndrome]
   966 E C3536911:Prion Disease [Pathologic Function]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0033164:Prion [Amino Acid, Peptide, or Protein]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "ALS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0154682:Lateral Sclerosis [Disease or Syndrome]
   827   C0036429:Sclerosis [Pathologic Function]
   827   C0205093:Lateral [Spatial Concept]
   755 E C0334135:Sclerotic [Functional Concept]

Phrase: "and"

Phrase: "the polyglutamine repeat disorders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012634:Disorders [Disease or Syndrome]

Phrase: "the aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "are"

Phrase: "the pathogenic agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "or"

Phrase: "simply markers of the cells demise."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.144: For polyglutamine disorders evidence is emerging that inhibiting the aggregation of the mutated protein will not prevent disease (30) but instead accelerates neurodegeneration. 

Phrase: "For polyglutamine disorders evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "emerging"

Phrase: "that inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the aggregation of the mutated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(30"

Phrase: ")"

Phrase: "but"

Phrase: "instead"

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.145: Moreover, in a recent paper, Passani et al. 

Phrase: "Moreover,"

Phrase: "in a recent paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030351:Paper [Manufactured Object]
   861   C1547566:Paper [Idea or Concept]

Phrase: "Passani et al."
Processing 00000000.tx.146: (31) observed that modification of mutant huntingtin in target neurons promotes an abnormal interaction with one or all of huntingtins WW domain partners, with toxic consequences, demonstrating that aberrant protein interactions play an important role in the pathogenesis of Huntingtons disease. 

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that modification of mutant huntingtin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]

Phrase: "in target neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "an abnormal interaction with one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "all of huntingtins WW domain partners,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0444868:All [Quantitative Concept]
   753   C0682323:partners [Family Group]
   753   C1861696:WW [Disease or Syndrome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3539085:All [Idea or Concept]
   753   C3541951:Domain [Intellectual Product]

Phrase: "with toxic consequences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]

Phrase: "demonstrating"

Phrase: "that aberrant protein interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0872079:protein interaction [Molecular Function]
   793   C1704675:Interaction [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the pathogenesis of Huntingtons disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.147: In this study we presented evidence that mutant tau protein not only is deposited in insoluble aggregates but must for the major part be partially digested by the cell. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that mutant tau protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   901   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "is"

Phrase: "deposited in insoluble aggregates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205418:aggregates [Qualitative Concept]
   770   C0333562:deposited [Functional Concept]

Phrase: "but"

Phrase: "must for the major part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205164:Major [Qualitative Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "be"

Phrase: "partially"

Phrase: "digested by the cell."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C0868946:digested [Physiologic Function]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.148: Detailed research into the processes that result from the presence of mutated tau, including factors that are involved in tau proteolysis and the formation of aggregates, will help us to understand the critical events that lead to neurodegeneration.  

Phrase: "Detailed research into the processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035168:research [Research Activity]
   760   C0242481:Research [Research Activity]

Phrase: "that"

Phrase: "result from the presence of mutated tau,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1705285:Mutated [Cell or Molecular Dysfunction]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   748   C2825142:Result [Finding]
   714 E C1513776:Mutate [Genetic Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "involved in tau proteolysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0597304:Proteolysis [Molecular Function]
   770   C1314939:Involved [Functional Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "the formation of aggregates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "will"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the critical events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "that"

Phrase: "lead to neurodegeneration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.149: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Patient materials Paraffin-embedded sections of frontal, temporal and parietal cortices, hippocampus and substantia nigra from three FTDP-17 patients with P301L mutation, (64, 66 and 73 years) (18,22,32), two AD, two non-demented controls and one FTDP-17 patient with an R406W mutation (18) were used for immunohistochemistry. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patient materials Paraffin-embedded sections of frontal, temporal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C0554924:patient section [Finding]
   711   C0205155:Section [Spatial Concept]
   711   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   711   C1522472:Section [Substance]
   711   C1552923:Section [Quantitative Concept]
   711   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "parietal cortices,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0030560:Parietal cortex [Body Part, Organ, or Organ Component]
   861   C0442030:Parietal [Spatial Concept]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "substantia nigra from three FTDP-17 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   778   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "with P301L mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(64,"

Phrase: "66"

Phrase: "and"

Phrase: "73 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "(18,"

Phrase: "22,"

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "two AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0002395:Alzheimers disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "two non-demented controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "one FTDP-17 patient with an R406W mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(18"

Phrase: ")"

Phrase: "were"

Phrase: "used for immunohistochemistry."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.150: Fresh frozen tissue from frontal and temporal cortices and cerebellum of three P301L patients (60, 63 and 73 years), one AD case, one DDPAC (E10 + 14 intronic mutation in tau) (4) and 1 non-demented control were used for biochemical studies. 

Phrase: "Fresh frozen tissue from frontal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1519521:Fresh Tissue [Tissue]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "temporal cortices"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   861   C0442043:Temporal [Spatial Concept]
   861   C2362314:Temporal [Temporal Concept]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "cerebellum of three P301L patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   760   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   760   C1707522:Cerebellum [Tissue]

Phrase: "(60,"

Phrase: "63"

Phrase: "and"

Phrase: "73 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "one AD case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0868928:Case [Functional Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]

Phrase: "one DDPAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(E10 + 14 intronic mutation in tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1881250:Intronic Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "(4"

Phrase: ")"

Phrase: "and"

Phrase: "1 non-demented control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "used for biochemical studies."
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   802   C0869040:Use studies [Research Activity]
   770   C0205474:Biochemical [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.151: The ages of the non-demented patients, the AD, DDPAC and R406W FTD patients were matched with the age of the P301L patients. 

Phrase: "The ages of the non-demented patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0001779:Age [Organism Attribute]

Phrase: "the AD,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "DDPAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "R406W FTD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "matched with the age of the P301L patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0001779:Age [Organism Attribute]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0150103:matched [Research Activity]
   744   C1708943:Matched [Qualitative Concept]
Processing 00000000.tx.152: Antibodies The following anti-tau antibodies were used: mouse monoclonal H-7 and AT8, rabbit polyclonal tau-P301 and tau-P301L. 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "The following anti-tau antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "mouse monoclonal H-7"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
   812   C0746619:monoclonal [Finding]

Phrase: "and"

Phrase: "AT8,"

Phrase: "rabbit polyclonal tau-P301"

Phrase: "and"

Phrase: "tau-P301L."
Processing 00000000.tx.153: H-7 is a phosphorylation-independent antibody which epitope maps at amino acids 157163 (33) (Innogenetics, Gent, Belgium). 

Phrase: "H-7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "is"

Phrase: "a phosphorylation-independent antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitope [Immunologic Factor]

Phrase: "maps at amino acids 157163"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   760   C0024779:Map [Manufactured Object]
   760   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1706473:Map [Conceptual Entity]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "(33"

Phrase: ")"

Phrase: "(Innogenetics,"

Phrase: "Gent,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")."
Processing 00000000.tx.154: AT8 recognizes human tau isoforms when phosphorylated at Ser202 and Thr205 (34) (Innogenetics). 

Phrase: "AT8"

Phrase: "recognizes"

Phrase: "human tau isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "when"

Phrase: "phosphorylated at Ser202"

Phrase: "and"

Phrase: "Thr205"

Phrase: "(34"

Phrase: ")"

Phrase: "(Innogenetics"

Phrase: ")."
Processing 00000000.tx.155: Two rabbit polyclonal antibodies were generated in our laboratory using synthetic peptides encoding amino acids 291305, numbered according to the longest tau isoform: CGSKDNIKHVPGGGS, for tau-P301 and CGSKDNIKHVLGGGS for tau-P301L. 

Phrase: "Two rabbit polyclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "generated in our laboratory"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C2346631:Laboratory-Generated [Qualitative Concept]
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3146294:Generated [Activity]
   770   C3244292:laboratory [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "amino acids 291305,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "numbered according to the longest tau isoform"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0449788:numbered [Quantitative Concept]
   748   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   748   C0680240:according [Social Behavior]
   748   C1522425:Longest [Qualitative Concept]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   714 E C0205166:Long [Qualitative Concept]
   714 E C0237753:*Number [Quantitative Concept]
   714 E C1706317:Long [Qualitative Concept]

Phrase: ":"

Phrase: "CGSKDNIKHVPGGGS,"

Phrase: "for tau-P301"

Phrase: "and"

Phrase: "CGSKDNIKHVLGGGS for tau-P301L."
Processing 00000000.tx.156: Immunohistochemistry For immunohistochemistry experiments paraffin sections were incubated with the polyclonal tau-P301 and tau-P301L antibodies (1:2000 dilution). 

Phrase: "Immunohistochemistry For immunohistochemistry experiments paraffin sections"

Phrase: "were"

Phrase: "incubated with the polyclonal tau-P301"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "tau-P301L antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ")."
Processing 00000000.tx.157: After endogenous peroxidase inhibition (35), the sections were subjected to antigen retrieval treatment using a microwave oven. 

Phrase: "After endogenous peroxidase inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "subjected to antigen retrieval treatment"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0003320:Antigen [Immunologic Factor]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1514918:Retrieval [Health Care Activity]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microwave oven."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0336756:Microwave oven [Manufactured Object]
   861   C0336755:Oven [Manufactured Object]
   861   C1706357:Oven [Medical Device]
Processing 00000000.tx.158: (35). 

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.159: Primary antibodies were incubated at 4C overnight and visualized with an indirect immunoperoxidase technique utilizing the HistostainPlus (Zymed, San Francisco, CA). 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "visualized with an indirect immunoperoxidase technique"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021067:Technique, Immunoperoxidase [Laboratory Procedure]
           Immunoperoxidase
   783   C0203939:Indirect technique [Therapeutic or Preventive Procedure]
   753   C0234621:Visualized [Functional Concept]
   753   C0439852:Indirect [Qualitative Concept]
   753   C0449851:Technique [Functional Concept]

Phrase: "utilizing"

Phrase: "the HistostainPlus"

Phrase: "(Zymed,"

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.160: As a test for labeling specificity, primary antibodies were absorbed with their respective peptides as described by Hoogeveen et al. 

Phrase: "As a test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "for labeling specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "absorbed with their respective peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "as"

Phrase: "described by Hoogeveen et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.161: (36). 

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.162: Background labeling was negligible. 

Phrase: "Background labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "negligible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332269:Negligible [Qualitative Concept]
Processing 00000000.tx.163: Staining with the AT8 antibody was carried out as described (22). 

Phrase: "Staining with the AT8 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.164: Plasmids and constructs Site-directed mutagenesis on a cDNA clone expressing the longest tau isoform was used to change P301 to a leucine in the longest tau isoform, with the Quick Change site-directed mutagenesis kit (Stratagene, La Jolla, CA). 

Phrase: "Plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "Site-directed mutagenesis on a cDNA clone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   748   C0079866:Mutagenesis [Molecular Function]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   748   C3146302:Mutagenesis [Laboratory Procedure]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "expressing"

Phrase: "the longest tau isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "P301 to a leucine"

Phrase: "in the longest tau isoform,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "with the Quick Change site-directed mutagenesis kit (Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)."
Processing 00000000.tx.165: Mutagenesis was performed according to the manufacturers instructions. 

Phrase: "Mutagenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079866:Mutagenesis [Molecular Function]
  1000   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "was"

Phrase: "performed according to the manufacturers instructions."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   753   C1442085:Instructions [Idea or Concept]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
   719   C0947322:Manufacturer [Intellectual Product]
   719   C1705426:Manufacturer [Population Group]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.166: DNA was isolated from the wild-type clone and its mutant, verified by sequencing using the BigDye Terminator Cycle sequencing kit (PE Biosystems, Foster City, CA) on an ABI 377 automated sequencer (PE Biosystems) and the tau cDNA was sub-cloned into CMV, pCDNA3 (Invitrogen, Carlsbad, CA) and pTRE vectors (Clontech, Palo Alto, CA). 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from the wild-type clone"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0009013:Clone [Cell]
   753   C0205409:Isolated [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1522642:Clone [Tissue]
   753   C1547052:*Type [Quantitative Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "its mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "verified by sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   790   C1711411:Verified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BigDye Terminator Cycle sequencing kit (PE Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA) on an ABI 377 automated sequencer"

Phrase: "(PE Biosystems"

Phrase: ")"

Phrase: "and"

Phrase: "the tau cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "sub-cloned into CMV,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0009013:cloned [Cell]
   770   C0542339:Sub- [Spatial Concept]
   770   C1264637:SUB [Quantitative Concept]
   737 E C1522642:Clone [Tissue]

Phrase: "pCDNA3"

Phrase: "(Invitrogen,"

Phrase: "Carlsbad,"

Phrase: "CA)"

Phrase: "and"

Phrase: "pTRE vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "(Clontech,"

Phrase: "Palo Alto,"

Phrase: "CA)."
Processing 00000000.tx.167: In vitro transcription and translation The longest tau isoform and its mutant P301L cloned in pCDNA3, were synthesized by in vitro transcription and translation in presence of [35S]methionine (Amersham Pharmacia Biotech, Little Chalfont, UK) using the TNT Coupled Reticulocyte Lysate system (Promega, Madison, WI) for 90 min at 30C. 

Phrase: "In vitro transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040649:Transcription [Genetic Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040712:Translation [Intellectual Product]
  1000   C0597295:translation [Molecular Function]
  1000   C1519614:Translation [Genetic Function]

Phrase: "The longest tau isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "its mutant P301L"

Phrase: "cloned in pCDNA3,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0009013:cloned [Cell]
   756 E C1522642:Clone [Tissue]

Phrase: "were"

Phrase: "synthesized by in vitro transcription"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0040649:Transcription [Genetic Function]
   760   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "translation in presence of [35S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040712:Translation [Intellectual Product]
   760   C0597295:translation [Molecular Function]
   760   C1519614:Translation [Genetic Function]

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Little Chalfont,"

Phrase: "UK"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the TNT"

Phrase: "Coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "Reticulocyte Lysate system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI) for 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043193:WI [Geographic Area]

Phrase: "at 30C."
Processing 00000000.tx.168: After adding 2x sample buffer, the samples were run on 10% polyacrylamide gel, dried and exposed to film. 

Phrase: "After"

Phrase: "adding 2x sample buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "run on 10% polyacrylamide gel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   804   C1382104:Gel [Substance]

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]
Processing 00000000.tx.169: Cell culture and transfection COS cells were cultured in Dulbeccos minimal Eagles medium (DMEM) supplemented with 10% (v/v) fetal calf serum (FCS) (Clontech), 100 IU/ml penicillin and 100 g/ml streptomycin (all from Gibco BRL, Bethesda, MD) and were kept at 37C in 5% CO2. 

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transfection COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0376702:COS Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in Dulbeccos minimal Eagles medium (DMEM)"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagles [Bird]
   753   C0439536:Medium [Quantitative Concept]
   753   C0547040:Minimal [Qualitative Concept]
   753   C1524031:MINIMAL [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C2945599:Minimal [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C1551720:Eagle [Population Group]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 10%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "(v/v) fetal calf serum (FCS)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0230445:Calf [Body Location or Region]
   804   C0521457:Fetal [Functional Concept]
   804   C1305418:Calf [Body Part, Organ, or Organ Component]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   748 E C0626053:sural [Pharmacologic Substance]

Phrase: "(Clontech"

Phrase: ")"

Phrase: ","

Phrase: "100 IU/ml penicillin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]
   756   C2346524:100 IU/mL [Quantitative Concept]

Phrase: "and"

Phrase: "100 g/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "("

Phrase: "all from Gibco BRL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C1412820:BRL [Gene or Genome]
   770   C3539085:All [Idea or Concept]

Phrase: "Bethesda,"

Phrase: "MD)"

Phrase: "and"

Phrase: "were"

Phrase: "kept at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0333118:Keep [Functional Concept]

Phrase: "in 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.170: PC12 cells were grown in DMEM supplemented with10% (v/v) horse serum (Sigma, St Louis, MO) and 5% (v/v) FCS (Clontech), 100 IU/ml penicillin and 100 g/ml streptomycin (Gibco BRL), and kept in 10% CO2. 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DMEM supplemented with10%"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   744   C0009458:Medium [Intellectual Product]
   744   C0325564:Eagles [Bird]
   744   C0439536:Medium [Quantitative Concept]
   744   C0547040:Minimal [Qualitative Concept]
   744   C1524031:MINIMAL [Qualitative Concept]
   744   C1705217:Medium [Substance]
   744   C2945599:Minimal [Qualitative Concept]
   744   C3244283:medium [Intellectual Product]
   711   C0242295:Supplement [Food]
   711 E C1551720:Eagle [Population Group]
   711   C1947943:Supplement [Intellectual Product]
   711   C2348609:Supplement [Functional Concept]

Phrase: "(v/v) horse serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1518416:Serum, Horse [Immunologic Factor]
   812   C0019944:Horse [Mammal]
   812   C0229671:Serum [Body Substance]
   812   C0242616:Horse [Mammal]
   812   C1265527:Horse [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "and"

Phrase: "5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(v/v) FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   804   C0015965:Fetal [Embryonic Structure]
   804   C0229671:Serum [Body Substance]
   804   C0230445:Calf [Body Location or Region]
   804   C0521457:Fetal [Functional Concept]
   804   C1305418:Calf [Body Part, Organ, or Organ Component]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   748 E C0626053:sural [Pharmacologic Substance]

Phrase: "(Clontech"

Phrase: ")"

Phrase: ","

Phrase: "100 IU/ml penicillin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]
   756   C2346524:100 IU/mL [Quantitative Concept]

Phrase: "and"

Phrase: "100 g/ml streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(Gibco BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "kept in 10% CO2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2347816:Co2+ [Element, Ion, or Isotope]
   737   C0333118:Keep [Functional Concept]
Processing 00000000.tx.171: COS cells were transiently transfected with pCDNA3 constructs mentioned above, using Lipofectamine reagent (Gibco BRL) according to the manufacturers recommendations. 

Phrase: "COS cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with pCDNA3"

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "mentioned above,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Gibco BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: "according to the manufacturers recommendations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034866:recommendations [Idea or Concept]
Processing 00000000.tx.172: PC12 cells were stably transfected with the wild-type and P301L tau cloned in pTRE vectors using the Tet-On Gene expression system (Clontech) (37). 

Phrase: "PC12 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085262:PC12 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "P301L tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "cloned in pTRE vectors"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0009013:cloned [Cell]
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1522642:Clone [Tissue]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Tet-On Gene expression system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515333:Tet [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Clontech"

Phrase: ")"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.173: Immunofluorescence Cells were rinsed twice in cold phosphate-buffered saline (PBS), fixed and permeabilized, essentially as described by Preuss et al. 

Phrase: "Immunofluorescence Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "twice in cold phosphate-buffered saline (PBS),"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0036082:Saline [Substance]
   753   C0234192:Cold [Physiologic Function]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   753   C1720725:Twice [Intellectual Product]
   753   C1948050:Twice [Quantitative Concept]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "permeabilized, essentially"

Phrase: "as"

Phrase: "described by Preuss et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.174: (38). 

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.175: The fixed cells were then incubated with tau-P301 and tau-P301L antibodies (1:100 dilution) for 1 h at room temperature and after washing in PBS with 0.5% bovine serum albumin and 0.15% glycine, were incubated with secondary fluorescein-conjugated goat anti-rabbit antibody (1:100 dilution; 

Phrase: "The fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with tau-P301"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "tau-P301L antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "and after washing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0441648:Washing [Activity]
   790   C1515981:And [Idea or Concept]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with 0.5% bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "0.15% glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0522461:Glycine [Plant]

Phrase: "were"

Phrase: "incubated with secondary fluorescein-conjugated goat anti-rabbit antibody"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0018019:goat [Mammal]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0027627:secondary [Neoplastic Process]
   742   C0034493:Rabbit [Mammal]
   742   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0175668:Secondary [Temporal Concept]
   742   C0205436:Secondary [Quantitative Concept]
   742   C0522529:Conjugated [Spatial Concept]
   742   C1265549:goat [Mammal]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1510458:Goat [Mammal]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.176: Sigma). 

Phrase: "Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: Cells were mounted in Vectashield mounting media (Vector, Burlingame, CA) and examined with a Leica DMXRA fluorescence microscope equipped with digital camera. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "mounted in Vectashield mounting media"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0972560:MOUNTING MEDIA [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0449878:mounted [Finding]
   760   C1254021:Media [Tissue]
   726 E C0181909:Mount [Medical Device]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "(Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA)"

Phrase: "and"

Phrase: "examined with a Leica DMXRA fluorescence microscope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0181839:Microscope [Medical Device]
   748   C0332128:Examined [Finding]
   748   C1706379:Microscope [Medical Device]

Phrase: "equipped with digital camera."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0179533:Camera [Medical Device]
   770   C0442015:Digital [Intellectual Product]
   770   C1654607:Camera [Eukaryote]
   770   C1706254:CAMERA [Medical Device]
   770   C1883674:Digital [Qualitative Concept]
   715 E C0016129:Finger [Body Location or Region]
   715 E C0549188:fingers [Quantitative Concept]
   715 E C1281584:Finger [Body Part, Organ, or Organ Component]
Processing 00000000.tx.178: Gel electrophoresis and immunoblotting Homogenates from transfected cells were prepared by lysing subconfluent cells on ice in lysis buffer (50 mM TrisCl pH 7.4, 1% Nonidet P-40, 1 mM MgCl2, 5 mM EGTA, 5 mM dithiothreitol, 120 mM NaCl, 100 M phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, 1 g/ml aprotinin, 1 g/ml pepstatin). 

Phrase: "Gel electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596607:Gel Electrophoresis [Laboratory Procedure]
   861   C0013855:Electrophoresis [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "immunoblotting Homogenates from transfected cells"

Phrase: "were"

Phrase: "prepared by lysing subconfluent cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0024348:lysing [Pathologic Function]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726   C1521827:Prepare [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "in lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(50 mM TrisCl pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C2678549:PH-4 [Gene or Genome]
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "1 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "5 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "120 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "100 M phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 g/ml leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "1 g/ml aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1 g/ml pepstatin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.179: Extracts were centrifuged immediately at 13 000 g for 10 min and the supernatants were used directly for SDSPAGE. 

Phrase: "Extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "immediately at 13 000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205548:Immediately [Temporal Concept]
   760   C0439267:g% [Quantitative Concept]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "directly for SDSPAGE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.180: No cross-reactivity was observed for tau-P301 antibody. 

Phrase: "No cross-reactivity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0010357:Cross Reactivity [Molecular Function]
  1000   C0872139:cross reactivity [Molecular Function]
  1000   C1880190:CROSS REACTIVITY [Event]
   861   C2828360:Cross [Conceptual Entity]
   789   C0205332:Reactive [Qualitative Concept]

Phrase: "was"

Phrase: "observed for tau-P301 antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1441672:Observed [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
Processing 00000000.tx.181: A faint band was visible in the tau 4R lane after incubation with tau-P301L antibody. 

Phrase: "A faint band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "visible in the tau 4R lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205379:Visible [Qualitative Concept]

Phrase: "after incubation"

Phrase: "with tau-P301L antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.182: However, quantitative analysis showed that the band intensity was <1% compared with the band in the tau P301L lane. 

Phrase: "However,"

Phrase: "quantitative analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0392762:Quantitative [Quantitative Concept]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the band intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "was <"

Phrase: "1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "compared with the band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0175723:Band [Medical Device]
   770   C0439645:Band [Spatial Concept]
   770   C1521913:band [Cell Component]
   770   C1707455:Compared [Activity]

Phrase: "in the tau P301L lane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.183: Sarkosyl-insoluble tau from brain was extracted and dephosphorylated as previously described (39). 

Phrase: "Sarkosyl-insoluble tau from brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "dephosphorylated"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.184: Samples were run on 10% SDSPAGE and electrophoretically transferred to a nitrocellulose membrane (Scheicher & Schuell, Dassell, Germany). 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "run on 10% SDSPAGE"

Phrase: "and"

Phrase: "electrophoretically"

Phrase: "transferred to a nitrocellulose membrane"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0348011:transferred [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "(Scheicher & Schuell,"

Phrase: "Dassell,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.185: Residual protein-binding sites were blocked by incubation in low fat milk for 1 h at room temperature. 

Phrase: "Residual protein-binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0005456:Binding Sites [Receptor]
   861   C0033618:Protein Binding [Molecular Function]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "blocked by incubation"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "in low fat milk"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
  1000   C0349375:low fat milk [Food]
  1000   C0452714:Low fat milk [Food]
   901   C0991850:fat milk [Lipid,Pharmacologic Substance]
   901   C1550569:low fat [Intellectual Product]
   827   C0026131:Milk [Body Substance]
   827   C0205251:low [Qualitative Concept]
   827   C0349374:Milk [Food]
   827   C0424612:FAT [Organism Attribute]
   827   C0444318:Milk [Substance]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.186: After 30 min of washing at room temperature in PBS containing 0.1% Tween 20, the first antibody (1:1000 and 1:2000 dilution for the polyclonal and monoclonal H-7 antibodies, respectively) was incubated for 1 h at room temperature or overnight at 4C in PBS + 0.1% Tween 20. 

Phrase: "After 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "of washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "the first antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000 dilution for the polyclonal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079240:Dilution [Laboratory Procedure]
   760   C1948037:Dilution [Functional Concept]

Phrase: "and"

Phrase: "monoclonal H-7 antibodies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   902   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0369286:H not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively"

Phrase: ")"

Phrase: "was"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "or"

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "in PBS + 0.1% Tween 20."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   818   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   801   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C0036082:Saline [Substance]
   795   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   790 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   740 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.187: Following 30 min of washing in PBS + 0.1% Tween 20 at room temperature, the nitrocellulose membrane was incubated 1 h at room temperatuare with the appropriate secondary antibody conjugated with horseradish peroxidase and the reaction products were visualized by using the ECL kit (Amersham Pharmacia Biotech). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "30 min of washing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "in PBS + 0.1% Tween 20"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   818   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   801   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C0036082:Saline [Substance]
   795   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   790 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   740 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "the nitrocellulose membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "1 h at room temperatuare"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0700308:1 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "with the appropriate secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "conjugated with horseradish peroxidase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "and"

Phrase: "the reaction products"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "visualized by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ECL kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.188: To determine the isoform composition of soluble tau present both in the affected and unaffected areas, the sarkosyl-soluble tau was concentrated 10x using Centricon devices (Millipore, Bedford, MA) and treated with protease inhibitor (Complete; Boehringer, Mannheim, Germany). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the isoform composition of soluble tau present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0486616:Composition [Clinical Attribute]
   748   C1555710:composition [Idea or Concept]

Phrase: "both in the affected"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0238767:Both [Spatial Concept]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "unaffected areas,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "the sarkosyl-soluble tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "10x"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Centricon devices"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025080:DEVICES [Medical Device]
   861   C0220819:devices [Manufactured Object]
   861   C0699733:Devices [Manufactured Object]

Phrase: "(Millipore,"

Phrase: "Bedford,"

Phrase: "MA)"

Phrase: "and"

Phrase: "treated with protease inhibitor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C3536890:Protease Inhibitor [Pharmacologic Substance]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   770   C1947941:Protease [Enzyme]
   770   C1999216:Inhibitor [Qualitative Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(Complete"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205197:Complete [Qualitative Concept]
  1000   C0725685:COMPLEAT [Food]
   928 E C0439812:Completeness [Qualitative Concept]

Phrase: "; Boehringer,"

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.189: Protein concentration was determined by using BCA protein assay (Pierce, Rockford, IL). 

Phrase: "Protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BCA protein assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.190: After dephosphorylation, equal amounts of protein for each patient were resolved by 10% SDSPAGE and the antibodies tau P301, tau-P301L and H-7 were used as described above. 

Phrase: "After dephosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158884:Dephosphorylation [Molecular Function]
  1000   C3160734:Dephosphorylation [Molecular Function]

Phrase: "equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "for each patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "were"

Phrase: "resolved by 10% SDSPAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514893:Resolved [Idea or Concept]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "the antibodies tau P301,"

Phrase: "tau-P301L"

Phrase: "and"

Phrase: "H-7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "used as described above."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C1552738:described [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.191: For quantitative immunoblot analysis Protein A labeled with 125I (Amersham Pharmacia Biotech) was used. 

Phrase: "For quantitative immunoblot analysis Protein A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "labeled with 125I"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.192: The radiolabeled tau bands were analyzed and quantified using Image master 1D elite software (Amersham Pharmacia Biotech). 

Phrase: "The radiolabeled tau bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Image master 1D elite software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.193: [35S]methionine pulsechase experiments COS cells transiently transfected with wild-type and P301L tau, were rinsed in PBS and incubated for 3 h in 5 ml of MetLeu-free DMEM containing 200 Ci of [35S]methionine-trans-labeled methionine (ICN, Irvine, CA). 

Phrase: "[35S"

Phrase: "]methionine pulsechase experiments COS cells transiently"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0376702:COS Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "P301L tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "were"

Phrase: "rinsed in PBS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726   C1701810:Rinse [Functional Concept]
   726   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "incubated for 3 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0041119:h 3 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 5 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "of MetLeu-free DMEM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0009458:Medium [Intellectual Product]
   799   C0439536:Medium [Quantitative Concept]
   799   C1705217:Medium [Substance]
   799   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "200 Ci of [35S"

Phrase: "]methionine-trans-labeled methionine"

Phrase: "(ICN,"

Phrase: "Irvine,"

Phrase: "CA)."
Processing 00000000.tx.194: Cells were then rinsed with 5 ml of PBS and incubated for chase intervals of 0, 6, 10 and 22 h in 10 ml of non-radioactive DMEM supplemented with 10% FCS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed with 5 ml of PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C0439526:/mL [Quantitative Concept]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   711   C1701810:Rinse [Functional Concept]
   711   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "incubated for chase intervals of 0,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C1272706:intervals [Temporal Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C1552654:Interval [Idea or Concept]
   719 E C1552713:Interval [Intellectual Product]

Phrase: "6,"

Phrase: "10"

Phrase: "and"

Phrase: "22 h in 10 ml of non-radioactive DMEM"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0439391:mL/h [Quantitative Concept]
   736   C0033727:H+ [Element, Ion, or Isotope]
   736   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0441932:H+ [Classification]
   736   C0564385:/h [Quantitative Concept]

Phrase: "supplemented with 10% FCS."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.195: Cells lysates were precipitated with H-7 monoclonal antibody overnight at 4C. 

Phrase: "Cells lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "precipitated with H-7 monoclonal antibody overnight"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   774   C0369286:H not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           H NOS
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0439583:Overnight [Temporal Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C0746619:monoclonal [Finding]
   714   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.196: The antibodyantigen complex was extracted from the lysate by incubating with Protein GSepharose (Amersham Pharmacia Biotech) for 1 h at 4C, followed by centrifugation for 1 min at 10 000 g. 

Phrase: "The antibodyantigen complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "extracted from the lysate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C1881488:Lysate [Physical Object]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "by incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:incubating [Laboratory Procedure]

Phrase: "with Protein GSepharose"

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "followed by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "for 1 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 10 000 g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.197: Protein GSepharose pellets were suspended in lysis buffer and rinsed three times. 

Phrase: "Protein GSepharose pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0993610:pellets [Biomedical or Dental Material]
   793 E C0441436:Pellet [Manufactured Object]
   793 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "suspended in lysis buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
   770   C1536403:lysis [Cell Function]
   770   C1553389:suspended [Idea or Concept]
   770   C1553403:suspended [Idea or Concept]
   770   C1705537:Suspended [Functional Concept]

Phrase: "and"

Phrase: "rinsed three times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.198: After adding sample buffer the sample was then electrophoresed in 10% polyacrylamide gel and vacuum-dried. 

Phrase: "After adding sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "electrophoresed in 10% polyacrylamide gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   760   C1382104:Gel [Substance]
   726   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "vacuum-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042221:Vacuum [Natural Phenomenon or Process]

Phrase: "dried."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]
Processing 00000000.tx.199: Radiolabeled tau bands were visualized and quantified by Image Master 1D elite software (Amersham Pharmacia Biotech).  

Phrase: "Radiolabeled tau bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "and"

Phrase: "quantified by Image Master 1D elite software"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0037585:Software [Intellectual Product,Manufactured Object]
   748   C0444649:Master [Qualitative Concept]
   748   C1416886:1D [Gene or Genome]
   748   C1442449:1D [Temporal Concept]
   748   C1704254:Image [Intellectual Product]
   748   C1704922:Image [Entity]
   748   C3542466:Image [Intellectual Product]
   714   C1709793:Quantify [Quantitative Concept]

Phrase: "(Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.200: ACKNOWLEDGEMENTS  The authors thank Dr Tim Lynch for providing brain material of the DDPAC patient, Dr Michel Goedert for the recombinant tau protein, and Marcel Hillebrand, Dr Mark Nellist, Wim van Noort and Jose Wouda for technical assistance. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Tim Lynch for providing brain material"

Phrase: "of the DDPAC patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030705:*^patient [Patient or Disabled Group]

Phrase: "Dr Michel Goedert for the recombinant tau protein,"

Phrase: "and"

Phrase: "Marcel Hillebrand,"

Phrase: "Dr Mark Nellist,"

Phrase: "Wim van Noort"

Phrase: "and"

Phrase: "Jose Wouda for technical assistance."
Processing 00000000.tx.201: This work was supported by grants from the Internationale Stichting Alzheimer Onderzoek and the Dutch Brain Foundation.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Internationale Stichting Alzheimer Onderzoek"

Phrase: "and"

Phrase: "the Dutch Brain Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.202: FOOTNOTES  + To whom correspondence should be addressed. 

Phrase: "FOOTNOTES  +"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.203: Tel: +31 10 408 8136; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+31 10 408 8136"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450355:31 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.204: Fax: +31 10 408 9489; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+31 10 408 9489"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450355:31 [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.205: Email: heutink@kgen.fgg.eur.nl  REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  1 Foster, N.L., Wilhelmsen, K., Sima, A.A., Jones, M.Z., DAmato, C.J. and Gilman, S. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "heutink@kgen.fgg.eur.nl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0027778:NL [Geographic Area]
   804   C0560008:nL [Quantitative Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]

Phrase: "N.L., Wilhelmsen,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sima,"

Phrase: "A."

Phrase: "A.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "M."

Phrase: "Z.,"

Phrase: "DAmato,"

Phrase: "C.J."

Phrase: "and"

Phrase: "Gilman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.206: (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Frontotemporal dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0236642:frontotemporal dementia [Disease or Syndrome]
  1000   C0338451:Frontotemporal dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "linked to chromosome 17"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: ":"

Phrase: "a consensus conference."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086047:Conference [Human-caused Phenomenon or Process]
Processing 00000000.tx.207: Ann. 

Phrase: "Ann."
Processing 00000000.tx.208: Neurol., 41, 706715.[ISI][Medline] 2 The Lund and Manchester Groups (1994) Clinical and neuropathological criteria for frontotemporal dementia. 

Phrase: "Neurol.,"

Phrase: "41,"

Phrase: "706715."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "The Lund"

Phrase: "and"

Phrase: "Manchester Groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(1994"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "neuropathological criteria for frontotemporal dementia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.209: J. 

Phrase: "J."
Processing 00000000.tx.210: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.211: Neurosurg. 

Phrase: "Neurosurg."
Processing 00000000.tx.212: Psychiatry, 57, 416418.[ISI][Medline] 3 Feany, M.B. and Dickson, D.W. 

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "57,"

Phrase: "416418."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 3 Feany,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Dickson,"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.213: (1996) Neurodegenerative disorders with extensive tau pathology: a comparative study and review. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neurodegenerative disorders with extensive tau pathology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   790   C1522560:Neurodegenerative Disorders [Functional Concept]
   753   C0012634:Disorders [Disease or Syndrome]
   748   C0030660:PATHOLOGICAL DISORDERS [Pathologic Function]

Phrase: ":"

Phrase: "a comparative study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009491:Comparative Study [Intellectual Product]
  1000   C1579762:comparative study [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "review."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]
Processing 00000000.tx.214: Ann. 

Phrase: "Ann."
Processing 00000000.tx.215: Neurol., 40, 139148.[ISI][Medline] 4 Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A. et al. 

Phrase: "Neurol.,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "139148."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 4 Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Lendon,"

Phrase: "C.L., Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pickering-Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "S."

Phrase: ","

Phrase: "Chakraverty,"

Phrase: "S."

Phrase: ","

Phrase: "Isaacs,"

Phrase: "A. et al."
Processing 00000000.tx.216: (1998) Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Association of missense"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "5'-splice-site mutations in tau"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1519478:Splice-Site Mutation [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "with the inherited dementia FTDP-17."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0338451:FTDP-17 [Disease or Syndrome]
   861   C1446659:FTDP-17 [Gene or Genome]
   861   C2697954:FTDP-17 [Gene or Genome]
Processing 00000000.tx.217: Nature, 393, 702705.[ISI][Medline] 5 Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., Andreadis, A., Wiederholt, W.C., Raskind, M. and Schellenberg, G.D. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "393,"

Phrase: "702705."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 5 Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Wijsman,"

Phrase: "E.,"

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Garruto,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Anderson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Wiederholt,"

Phrase: "W.C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellum [Tissue]

Phrase: "Raskind,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.218: (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "a candidate gene for chromosome 17 frontotemporal dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1332838:Candidate Gene [Gene or Genome]
   767   C0079429:A Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.219: Ann. 

Phrase: "Ann."
Processing 00000000.tx.220: Neurol., 43, 815825. 

Phrase: "Neurol.,"

Phrase: "43,"

Phrase: "815825."
Processing 00000000.tx.221: [Erratum (1998) Ann. Neurol., 44, 428.][ISI][Medline] 6 Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A. and Ghetti, B. 

Phrase: "[Erratum"

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann. Neurol.,"

Phrase: "44,"

Phrase: "428."

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 6 Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Murrell,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Farlow,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Klug,"

Phrase: "A."

Phrase: "and"

Phrase: "Ghetti,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.222: (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutation in the tau gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596611:Gene Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in familial multiple system tauopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "with presenile dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011265:Pre-senile dementia [Mental or Behavioral Dysfunction]
           dementia
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.223: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.224: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.225: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.226: USA, 95, 77377741.[Abstract/Free FullText] 7 Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and Crowther, R.A. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "77377741."

Phrase: "[Abstract/Free FullText"

Phrase: "] 7 Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rutherford,"

Phrase: "D."

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.227: (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimers disease. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Multiple isoforms of human microtubule-associated protein tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   703   C1454489:microtubule-associated protein tau, human [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "localization in neurofibrillary tangles of Alzheimers disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.228: Neuron, 3, 519526.[ISI][Medline] 8 Mandell, J.W. and Banker, G.A. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "519526."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 8 Mandell,"

Phrase: "J.W."

Phrase: "and"

Phrase: "Banker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.229: (1996) Microtubule-associated proteins, phosphorylation gradients, and the establishment of neuronal polarity. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Microtubule-associated proteins,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0026045:Microtubule-Associated Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0026042:Microtubule Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "phosphorylation gradients,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]

Phrase: "and"

Phrase: "the establishment of neuronal polarity."
Processing 00000000.tx.230: Perspect. 

Phrase: "Perspect."
Processing 00000000.tx.231: Dev. 

Phrase: "Dev."
Processing 00000000.tx.232: Neurobiol., 4, 125135.[ISI][Medline] 9 Goedert, M., Crowther, R.A. and Garner, C.C. 

Phrase: "Neurobiol.,"

Phrase: "4,"

Phrase: "125135."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 9 Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."

Phrase: "and"

Phrase: "Garner,"

Phrase: "C.C."
Processing 00000000.tx.233: (1991) Molecular characterization of microtubule-associated proteins tau and MAP2. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Molecular characterization of microtubule-associated proteins tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "MAP2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417006:MAP2 [Gene or Genome]
  1000   C1424480:MAP2 [Gene or Genome]
Processing 00000000.tx.234: Trends Neurosci., 14, 193199.[ISI][Medline] 10 Hirokawa, N. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "14,"

Phrase: "193199."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 10 Hirokawa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.235: (1994) Microtubule organization and dynamics dependent on microtubule-associated proteins. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Microtubule organization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "and"

Phrase: "dynamics"

Phrase: "dependent on microtubule-associated proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.236: Curr. 

Phrase: "Curr."
Processing 00000000.tx.237: Opin. 

Phrase: "Opin."
Processing 00000000.tx.238: Cell Biol., 6, 7481.[ISI][Medline] 11 Sato-Harada, R., Okabe, S., Umeyama, T., Kanai, Y. and Hirokawa, N. 

Phrase: "Cell Biol.,"

Phrase: "6,"

Phrase: "7481."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 11 Sato-Harada,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Okabe,"

Phrase: "S."

Phrase: ","

Phrase: "Umeyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kanai,"

Phrase: "Y."

Phrase: "and"

Phrase: "Hirokawa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.239: (1996) Microtubule-associated proteins regulate microtubule function as the track for intracellular membrane organelle transports. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Microtubule-associated proteins"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0026045:Microtubule-Associated Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C0026042:Microtubule Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0026046:Micro-tubule [Cell Component]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "regulate"

Phrase: "microtubule function as the track"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "for intracellular membrane organelle transports."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0599814:Intracellular Transport [Cell Function]
   875   C1519624:Membrane Transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
   708   C1523867:intracellular organelle [Cell Component]
Processing 00000000.tx.240: Cell Struct. 

Phrase: "Cell Struct."
Processing 00000000.tx.241: Funct., 21, 283295.[ISI][Medline] 12 Trinczek, B., Ebneth, A., Mandelkow, E.M. and Mandelkow, E. 

Phrase: "Funct.,"

Phrase: "21,"

Phrase: "283295."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 12 Trinczek,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ebneth,"

Phrase: "A.,"

Phrase: "Mandelkow,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.242: (1999) Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "regulates"

Phrase: "the attachment/detachment"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0541879:detachment [Mental Process]
   861   C0595950:Detachment [Pathologic Function]
   789 E C0687118:Detached [Functional Concept]
   789 E C1561504:detached [Idea or Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the speed of motors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678536:Speed [Quantitative Concept]

Phrase: "in microtubule-dependent transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "of single vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "organelles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelles [Cell Component]
Processing 00000000.tx.243: J. 

Phrase: "J."
Processing 00000000.tx.244: Cell Sci., 112, 23552367.[Abstract/Free FullText] 13 Heutink, P. 

Phrase: "Cell Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]

Phrase: "112,"

Phrase: "23552367."

Phrase: "[Abstract/Free FullText"

Phrase: "] 13 Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.245: (2000) Untangling tau-related dementia. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Untangling tau-related dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0011265:dementia [Mental or Behavioral Dysfunction]
   812   C0497327:Dementia [Mental or Behavioral Dysfunction]
   712 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.246: Hum. 

Phrase: "Hum."
Processing 00000000.tx.247: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.248: Genet., 9, 979986.[Abstract/Free FullText] 14 DSouza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V.M., Bird, T.D. and Schellenberg, G.D. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "979986."

Phrase: "[Abstract/Free FullText"

Phrase: "] 14 DSouza,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Nochlin,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T.D."

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.249: (1999) Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Missense"

Phrase: "and"

Phrase: "silent tau gene mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   886   C1519323:Silent Mutation [Genetic Function]
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "frontotemporal dementia with parkinsonism-chromosome 17 type,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   879   C0338451:Frontotemporal Dementia with Parkinsonism-17 [Disease or Syndrome]
           Frontotemporal Dementia with Parkinsonism
           Frontotemporal dementia
   814   C0349081:Dementia with Parkinsonism [Disease or Syndrome]
   778   C0236642:frontotemporal dementia [Disease or Syndrome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "by affecting multiple alternative RNA splicing regulatory elements."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   795   C0013879:Elements [Element, Ion, or Isotope]
   795   C0220905:regulatory [Regulation or Law]
   795   C1704735:Regulatory [Conceptual Entity]
   785   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   762 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.250: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.251: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.252: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.253: USA, 96, 55985603.[Abstract/Free FullText] 15 Hasegawa, M., Smith, M.J., Iijima, M., Tabira, T. and Goedert, M. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "96,"

Phrase: "55985603."

Phrase: "[Abstract/Free FullText"

Phrase: "] 15 Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."

Phrase: "J.,"

Phrase: "Iijima,"

Phrase: "M."

Phrase: ","

Phrase: "Tabira,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.254: (1999) FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. 

Phrase: "(1999"

Phrase: ")"

Phrase: "FTDP-17 mutations N279K"

Phrase: "and"

Phrase: "S305N in tau"

Phrase: "produce"

Phrase: "increased splicing of exon 10."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035687:Splicing [Genetic Function]
   760   C2610186:splicing [Genetic Function]
Processing 00000000.tx.255: FEBS Lett., 443, 9396.[ISI][Medline] 16 Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B.I., Geschwind, D.H., Bird, T.D., McKeel, D., Goate, A. et al. 

Phrase: "FEBS Lett.,"

Phrase: "443,"

Phrase: "9396."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 16 Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Zhukareva,"

Phrase: "V.,"

Phrase: "Vogelsberg-Ragaglia,"

Phrase: "V.,"

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Reed,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Geschwind,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "McKeel,"

Phrase: "D."

Phrase: ","

Phrase: "Goate,"

Phrase: "A. et al."
Processing 00000000.tx.256: (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutation-specific functional impairments in distinct tau isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0684336:Impairments [Pathologic Function]
   744   C2598156:Impairments [Clinical Attribute]

Phrase: "of hereditary FTDP-17."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0338451:FTDP-17 [Disease or Syndrome]
   901   C1446659:FTDP-17 [Gene or Genome]
   901   C2697954:FTDP-17 [Gene or Genome]
Processing 00000000.tx.257: Science, 282, 19141917.[Abstract/Free FullText] 17 Rizzu, P., Van Swieten, J.C., Joosse, M., Hasegawa, M., Stevens, M., Tibben, A., Niermeijer, M.F., Hillebrand, M., Ravid, R., Oostra, B.A. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "282,"

Phrase: "19141917."

Phrase: "[Abstract/Free FullText"

Phrase: "] 17 Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Van Swieten,"

Phrase: "J.C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellum [Tissue]

Phrase: "Joosse,"

Phrase: "M."

Phrase: ","

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Tibben,"

Phrase: "A.,"

Phrase: "Niermeijer,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hillebrand,"

Phrase: "M."

Phrase: ","

Phrase: "Ravid,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Oostra,"

Phrase: "B.A. etal."
Processing 00000000.tx.258: (1999) High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. 

Phrase: "(1999"

Phrase: ")"

Phrase: "High prevalence of mutations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1512456:High Prevalence [Quantitative Concept]
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "in the microtubule-associated protein tau"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
  1000   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1421563:protein tau [Gene or Genome]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a population study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681876:Population Study [Research Activity]
   861   C0032659:Population [Quantitative Concept]
   861   C0557651:Study [Manufactured Object]
   861   C1257890:Population [Population Group]
   861   C2603343:Study [Research Activity]

Phrase: "of frontotemporal dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0236642:frontotemporal dementia [Disease or Syndrome]
  1000   C0338451:Frontotemporal dementia [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "in the Netherlands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands
Processing 00000000.tx.259: Am. 

Phrase: "Am."
Processing 00000000.tx.260: J. 

Phrase: "J."
Processing 00000000.tx.261: Hum. 

Phrase: "Hum."
Processing 00000000.tx.262: Genet., 64, 414421.[ISI][Medline] 18 van Swieten, J.C., Stevens, M., Rosso, S.M., Rizzu, P., Joosse, M., de Koning, I., Kamphorst, W., Ravid, R., Spillantini, M.G., Niermeijer and Heutink, P. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "64,"

Phrase: "414421."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 18 van Swieten,"

Phrase: "J.C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellum [Tissue]

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Rosso,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Joosse,"

Phrase: "M."

Phrase: ","

Phrase: "de Koning,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kamphorst,"

Phrase: "W.,"

Phrase: "Ravid,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Niermeijer"

Phrase: "and"

Phrase: "Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.263: (1999) Phenotypic variation in hereditary frontotemporal dementia with tau mutations. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Phenotypic variation in hereditary frontotemporal dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1836717:Phenotypic variation [Finding]
   753   C0205419:Variation [Qualitative Concept]

Phrase: "with tau mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.264: Ann. 

Phrase: "Ann."
Processing 00000000.tx.265: Neurol., 46, 617626.[ISI][Medline] 19 Dumanchin, C., Camuzat, A., Campion, D., Verpillat, P., Hannequin, D., Dubois, B., Saugier-Veber, P., Martin, C., Penet, C., Charbonnier, F. et al. 

Phrase: "Neurol.,"

Phrase: "46,"

Phrase: "617626."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 19 Dumanchin,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "Camuzat,"

Phrase: "A.,"

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Verpillat,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hannequin,"

Phrase: "D."

Phrase: ","

Phrase: "Dubois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Saugier-Veber,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Martin,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "Penet,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "Charbonnier,"

Phrase: "F. et al."
Processing 00000000.tx.266: (1998) Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Segregation of a missense mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "in the microtubule-associated protein tau gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1446659:Microtubule-Associated Protein Tau Gene [Gene or Genome]
           MICROTUBULE-ASSOCIATED PROTEIN TAU
   853   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   771   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
   722   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with familial frontotemporal dementia"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0751071:Familial Dementia [Mental or Behavioral Dysfunction]
   901   C0236642:frontotemporal dementia [Disease or Syndrome]
   901   C0338451:Frontotemporal dementia [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.267: Hum. 

Phrase: "Hum."
Processing 00000000.tx.268: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.269: Genet., 7, 18251829.[Abstract/Free FullText] 20 Mirra, S.S., Murrell, J.R., Gearing, M., Spillantini, M.G., Goedert, M., Crowther, R.A., Levey, A.I., Jones, R., Green, J. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "18251829."

Phrase: "[Abstract/Free FullText"

Phrase: "] 20 Mirra,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Murrell,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gearing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706469:Gear [Qualitative Concept]
   966   C1706470:Gear [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Levey,"

Phrase: "A.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "J. et al."
Processing 00000000.tx.270: (1999) Tau pathology in a family with dementia and a P301L mutation in tau. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Tau pathology in a family"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "a P301L mutation in tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.271: J. 

Phrase: "J."
Processing 00000000.tx.272: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.273: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.274: Neurol., 58, 335345.[ISI][Medline] 21 Clark, L.N., Poorkaj, P., Wszolek, Z., Geschwind, D.H., Nasreddine, Z.S., Miller, B., Li, D., Payami, H., Awert, F., Markopoulou, K. et al. 

Phrase: "Neurol.,"

Phrase: "58,"

Phrase: "335345."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 21 Clark,"

Phrase: "L.N., Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Geschwind,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nasreddine,"

Phrase: "Z.S.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "D."

Phrase: ","

Phrase: "Payami,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Awert,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Markopoulou,"

Phrase: "K. et al."
Processing 00000000.tx.275: (1998) Pathogenic implications of mutations in the tau gene in pallido-pontonigral degeneration and related neurodegenerative disorders linked to chromosome 17. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Pathogenic implications of mutations"

Phrase: "in the tau gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "in pallido-pontonigral degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "related neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   901   C1522560:Neurodegenerative Disorders [Functional Concept]
   827   C0012634:Disorders [Disease or Syndrome]

Phrase: "linked to chromosome 17."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008659:Chromosome 17 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.276: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.277: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.278: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.279: USA, 95, 1310313107.[Abstract/Free FullText] 22 Spillantini, M.G., Crowther, R.A., Kamphorst, W., Heutink, P. and van Swieten, J.C. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "1310313107."

Phrase: "[Abstract/Free FullText"

Phrase: "] 22 Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Kamphorst,"

Phrase: "W.,"

Phrase: "Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "van Swieten,"

Phrase: "J.C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.280: (1998) Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Tau pathology in two Dutch families"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the microtubule-binding region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C1183338:Microtubule region [Cell Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]
   734   C1149274:microtubule binding [Molecular Function]

Phrase: "of tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]
Processing 00000000.tx.281: Am. 

Phrase: "Am."
Processing 00000000.tx.282: J. 

Phrase: "J."
Processing 00000000.tx.283: Pathol., 153, 13591363.[Abstract/Free FullText] 23 Hasegawa, M., Smith, M.J. and Goedert, M. 

Phrase: "Pathol.,"

Phrase: "153,"

Phrase: "13591363."

Phrase: "[Abstract/Free FullText"

Phrase: "] 23 Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."

Phrase: "J."

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.284: (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Tau proteins with FTDP-17 mutations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C1421563:protein tau [Gene or Genome]
   756 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "have"

Phrase: "a reduced ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "microtubule assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.285: FEBS Lett., 437, 207210.[ISI][Medline] 24 DeTure, M., Ko, L.W., Yen, S., Nacharaju, P., Easson, C., Lewis, J., van Slegtenhorst, M., Hutton, M. and Yen, S.H. 

Phrase: "FEBS Lett.,"

Phrase: "437,"

Phrase: "207210."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 24 DeTure,"

Phrase: "M."

Phrase: ","

Phrase: "Ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "L.W., Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Nacharaju,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Easson,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "Lewis,"

Phrase: "J.,"

Phrase: "van Slegtenhorst,"

Phrase: "M."

Phrase: ","

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.286: (2000) Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Missense tau mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0599155:Mutations, Missense [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in FTDP-17"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0338451:FTDP-17 [Disease or Syndrome]
   833   C1446659:FTDP-17 [Gene or Genome]
   833   C2697954:FTDP-17 [Gene or Genome]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "have"

Phrase: "a small effect on tau-microtubule interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.287: Brain Res., 853, 514.[ISI][Medline] 25 Arrasate, M., Perez, M., Armas-Portela, R. and Avila, J. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "853,"

Phrase: "514."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 25 Arrasate,"

Phrase: "M."

Phrase: ","

Phrase: "Perez,"

Phrase: "M."

Phrase: ","

Phrase: "Armas-Portela,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Avila,"

Phrase: "J."
Processing 00000000.tx.288: (1999) Polymerization of tau peptides into fibrillar structures. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Polymerization of tau peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0314672:Polymerisation [Phenomenon or Process]

Phrase: "into fibrillar structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]
Processing 00000000.tx.289: The effect of FTDP-17 mutations. 

Phrase: "The effect of FTDP-17 mutations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.290: FEBS Lett., 446, 199202.[ISI][Medline] 26 Goedert, M., Jakes, R. and Crowther, R.A. 

Phrase: "FEBS Lett.,"

Phrase: "446,"

Phrase: "199202."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 26 Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.291: (1999) Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Effects of frontotemporal dementia FTDP-17 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on heparin-induced assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "of tau filaments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.292: FEBS Lett., 450, 306311.[ISI][Medline] 27 Nacharaju, P., Lewis, J., Easson, C., Yen, S., Hackett, J., Hutton, M. and Yen, S.H. 

Phrase: "FEBS Lett.,"

Phrase: "450,"

Phrase: "306311."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 27 Nacharaju,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lewis,"

Phrase: "J.,"

Phrase: "Easson,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Hackett,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.293: (1999) Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Accelerated filament formation from tau protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597295:protein formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "with specific FTDP-17 missense mutations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C0599155:Mutations, Missense [Genetic Function]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.294: FEBS Lett., 447, 195199.[ISI][Medline] 28 Litersky, J.M. and Johnson, G.V. 

Phrase: "FEBS Lett.,"

Phrase: "447,"

Phrase: "195199."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 28 Litersky,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Johnson,"

Phrase: "G.V."
Processing 00000000.tx.295: (1995) Phosphorylation of tau in situ: inhibition of calcium-dependent proteolysis. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "in situ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444498:In situ [Spatial Concept]

Phrase: ":"

Phrase: "inhibition of calcium-dependent proteolysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C2249698:inhibition of proteolysis [Organism Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
Processing 00000000.tx.296: J. 

Phrase: "J."
Processing 00000000.tx.297: Neurochem., 65, 903911.[ISI][Medline] 29 Yen, S., Easson, C., Nacharaju, P., Hutton, M. and Yen, S.H. 

Phrase: "Neurochem.,"

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "903911."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 29 Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Easson,"

Phrase: "C.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "Nacharaju,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.298: (1999) FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion. 

Phrase: "(1999"

Phrase: ")"

Phrase: "FTDP-17 tau mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the susceptibility of tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to calpain I digestion."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0012238:Digestion [Organism Function]
   827   C2349986:Digestion [Research Activity]
   771 E C0443277:Peptic [Functional Concept]
   734   C0006785:Calpain I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.299: FEBS Lett., 461, 9195.[ISI][Medline] 30 Cummings, C.J., Reinstein, E., Sun, Y., Antalffy, B., Jiang, Y., Ciechanover, A., Orr, H.T., Beaudet, A.L. and Zoghbi, H.Y. 

Phrase: "FEBS Lett.,"

Phrase: "461,"

Phrase: "9195."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 30 Cummings,"

Phrase: "C.J.,"

Phrase: "Reinstein,"

Phrase: "E.,"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Antalffy,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Ciechanover,"

Phrase: "A.,"

Phrase: "Orr,"

Phrase: "H.T.,"

Phrase: "Beaudet,"

Phrase: "A.L."

Phrase: "and"

Phrase: "Zoghbi,"

Phrase: "H.Y."
Processing 00000000.tx.300: (1999) Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mutation of the E6-AP ubiquitin ligase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "reduces"

Phrase: "nuclear inclusion frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]
   734   C1366904:Nuclear Inclusion [Cell Component]

Phrase: "while"

Phrase: "accelerating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0521110:accelerate [Functional Concept]

Phrase: "polyglutamine-induced pathology in SCA1 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.301: Neuron, 24, 879892.[ISI][Medline] 31 Passani, L.A., Bedford, M.T., Faber, P.W., McGinnis, K.M., Sharp, A.H., Gusella, J.F., Vonsattel, J.P. and MacDonald, M.E. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "24,"

Phrase: "879892."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 31 Passani,"

Phrase: "L.A.,"

Phrase: "Bedford,"

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Faber,"

Phrase: "P.W., McGinnis,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sharp,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1444775:Sharp [Finding]
  1000   C1539835:SHARP [Gene or Genome]

Phrase: "A.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Gusella,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Vonsattel,"

Phrase: "J.P."

Phrase: "and"

Phrase: "MacDonald,"

Phrase: "M."

Phrase: "E."
Processing 00000000.tx.302: (2000) Huntingtins WW domain partners in Huntingtons disease post-mortem brain fulfill genetic criteria for direct involvement in Huntingtons disease pathogenenssis. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Huntingtins WW domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1861696:WW [Disease or Syndrome]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "partners in Huntingtons disease post-mortem brain"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0004398:postmortem [Diagnostic Procedure]
   778   C0020179:Huntington Disease [Disease or Syndrome]
   778   C0580205:Postmortem [Temporal Concept]
   778   C0848632:post mortem [Finding]
   778   C2919056:Huntington's Disease [Functional Concept]
   774   C0006111:Brain Disease [Disease or Syndrome]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0682323:Partner [Family Group]
   748   C0687676:Post [Temporal Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1704687:Post [Manufactured Object]

Phrase: "fulfill"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Fulfill [Idea or Concept]

Phrase: "genetic criteria for direct involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243161:criteria [Intellectual Product]

Phrase: "in Huntingtons disease pathogenenssis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0020179:Huntington Disease [Disease or Syndrome]
   734   C2919056:Huntington's Disease [Functional Concept]
Processing 00000000.tx.303: Hum. 

Phrase: "Hum."
Processing 00000000.tx.304: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.305: Genet., 9, 21752182.[Abstract/Free FullText] 32 Heutink, P., Stevens, M., Rizzu, P., Bakker, E., Kros, J.M., Tibben, A., Niermeijer, M.F., van Duijn, C.M., Oostra, B.A. and van Swieten, J.C. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "9,"

Phrase: "21752182."

Phrase: "[Abstract/Free FullText"

Phrase: "] 32 Heutink,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Stevens,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551756:Stevens [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bakker,"

Phrase: "E.,"

Phrase: "Kros,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Tibben,"

Phrase: "A.,"

Phrase: "Niermeijer,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Oostra,"

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "van Swieten,"

Phrase: "J.C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   861   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.306: (1997) Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Hereditary frontotemporal dementia"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0236642:frontotemporal dementia [Disease or Syndrome]
   901   C0338451:Frontotemporal dementia [Disease or Syndrome]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "linked to chromosome 17q21-q22"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1520769:17q21-q22 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C1520768:17q21 [Cell Component]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: ":"

Phrase: "a genetic"
Meta Candidates (Total=16; Excluded=14; Pruned=0; Remaining=2)
  1000   C0017296:GENETIC [Therapeutic or Preventive Procedure]
  1000   C0314603:Genetic [Functional Concept]
   944 E C0005615:Birth [Organism Function]
   944 E C0035150:Reproduction [Organism Function]
   944 E C0079946:origin [Classification]
   944 E C0439659:Origin [Temporal Concept]
   944 E C1550512:origin [Intellectual Product]
   944 E C1550722:birth [Idea or Concept]
   944 E C3245487:birth [Intellectual Product]
   916 E C0454729:Natal [Geographic Area]
   916 E C0559522:Genital [Body System]
   916 E C1546649:Genital [Intellectual Product]
   916 E C1550642:Genital [Body Substance]
   907 E C0205313:Original [Idea or Concept]
   907 E C2347409:Original [Occupational Activity]
   888 E C0598240:originality [Mental Process]

Phrase: "and"

Phrase: "clinicopathological study of three Dutch families."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0199236:Family study, NOS [Diagnostic Procedure]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.307: Ann. 

Phrase: "Ann."
Processing 00000000.tx.308: Neurol., 41, 150159.[ISI][Medline] 33 Mercken, M., Vandermeeren, M., Lubke, U., Six, J., Boons, J., Van de Voorde, A., Martin, J.J. and Gheuens, J. 

Phrase: "Neurol.,"

Phrase: "41,"

Phrase: "150159."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 33 Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Vandermeeren,"

Phrase: "M."

Phrase: ","

Phrase: "Lubke,"

Phrase: "U.,"

Phrase: "Six,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "J.,"

Phrase: "Boons,"

Phrase: "J.,"

Phrase: "Van de Voorde,"

Phrase: "A.,"

Phrase: "Martin,"

Phrase: "J.J."

Phrase: "and"

Phrase: "Gheuens,"

Phrase: "J."
Processing 00000000.tx.309: (1992) Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Monoclonal antibodies with selective specificity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   797   C0003264:antibodies specificity [Molecular Function]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0746619:monoclonal [Finding]
   745 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for Alzheimer Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "are"

Phrase: "directed against phosphatase-sensitive epitopes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003316:Epitopes [Immunologic Factor]
   760   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332324:Sensitive [Functional Concept]
   760   C1149880:phosphatase [Molecular Function]
   760   C1550474:sensitive [Idea or Concept]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.310: Acta Neuropathol., 84, 265272.[ISI][Medline] 34 Greenberg, S.G. and Davies, P. 

Phrase: "Acta Neuropathol.,"

Phrase: "84,"

Phrase: "265272."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 34 Greenberg,"

Phrase: "S.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Davies,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.311: (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. 

Phrase: "(1990"

Phrase: ")"

Phrase: "A preparation of Alzheimer paired helical filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0455052:Preparation [Health Care Activity]
   748   C1521827:Preparation [Functional Concept]

Phrase: "that"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "distinct tau proteins by polyacrylamide gel electrophoresis."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0201719:electrophoresis proteins [Laboratory Procedure]
   757 E C1421563:protein tau [Gene or Genome]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]
   745 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.312: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.313: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.314: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.315: USA, 87, 58275831.[Abstract] 35 Devys, D., Lutz, Y., Rouyer, N., Bellocq, J.P. and Mandel, J.L. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "87,"

Phrase: "58275831."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 35 Devys,"

Phrase: "D."

Phrase: ","

Phrase: "Lutz,"

Phrase: "Y.,"

Phrase: "Rouyer,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bellocq,"

Phrase: "J.P."

Phrase: "and"

Phrase: "Mandel,"

Phrase: "J.L."
Processing 00000000.tx.316: (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. 

Phrase: "(1993"

Phrase: ")"

Phrase: "The FMR-1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "cytoplasmic,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010834:Cytoplasmic [Cell Component]
  1000   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "most abundant in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346714:Abundant [Qualitative Concept]

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "normal in carriers of a fragile X premutation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.317: Nature Genet., 4, 335340.[ISI][Medline] 36 Hoogeveen, A.T., Willemsen, R., Meyer, N., de Rooij, K.E., Roos, R.A., van Ommen, G.J. and Galjaard, H. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "335340."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 36 Hoogeveen,"

Phrase: "A.T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0193959:a t [Therapeutic or Preventive Procedure]

Phrase: "Willemsen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Meyer,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "de Rooij,"

Phrase: "K.E.,"

Phrase: "Roos,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "van Ommen,"

Phrase: "G.J."

Phrase: "and"

Phrase: "Galjaard,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.318: (1993) Characterization and localization of the Huntington disease gene product. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "localization of the Huntington disease gene product."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0008630:Gene Localization [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.319: Hum. 

Phrase: "Hum."
Processing 00000000.tx.320: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.321: Genet., 2, 20692073.[Abstract] 37 Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W. and Bujard, H. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "20692073."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 37 Gossen,"

Phrase: "M."

Phrase: ","

Phrase: "Freundlieb,"

Phrase: "S."

Phrase: ","

Phrase: "Bender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0491941:BENDER [Medical Device]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Muller,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hillen,"

Phrase: "W."

Phrase: "and"

Phrase: "Bujard,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.322: (1995) Transcriptional activation by tetracyclines in mammalian cells. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Transcriptional activation by tetracyclines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0162493:Transcriptional Activation [Genetic Function]
   770   C1879547:Activation [Activity]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.323: Science, 268, 17661769.[ISI][Medline] 38 Preuss, U., Doring, F., Illenberger, S. and Mandelkow, E.M. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "268,"

Phrase: "17661769."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 38 Preuss,"

Phrase: "U.,"

Phrase: "Doring,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Illenberger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: (1995) Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell cycle-dependent phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "microtubule binding of tau protein stably"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   820   C1323348:tau protein binding [Molecular Function]
   814   C0085401:Microtubule protein tau [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1149274:microtubule binding [Molecular Function]
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0026046:Micro-tubule [Cell Component]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "transfected into Chinese hamster ovary cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   864   C0085080:cells chinese hamster ovary [Cell]
   790   C0018555:Chinese Hamster [Mammal]
   753   C0007634:Cells [Cell]
   753   C0008120:chinese [Language]
   753   C0018557:Hamster [Mammal]
   753   C0029939:Ovary [Body Part, Organ, or Organ Component]
   753   C0152035:Chinese [Population Group]
   753   C0227898:ovary [Body Part, Organ, or Organ Component]
   753   C1278992:Ovary [Body Part, Organ, or Organ Component]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.325: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.326: Biol. 

Phrase: "Biol."
Processing 00000000.tx.327: Cell, 6, 13971410.[Abstract] 39 Goedert, M., Spillantini, M.G., Cairns, N.J. and Crowther, R.A. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "6,"

Phrase: "13971410."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 39 Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cairns,"

Phrase: "N.J."

Phrase: "and"

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A."
Processing 00000000.tx.328: (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Tau proteins of Alzheimer paired helical filaments"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   823   C2700455:Paired Helical Filament-Tau [Amino Acid, Peptide, or Protein]
       E   Tau Protein
   778   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C1421563:protein tau [Gene or Genome]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: ":"

Phrase: "abnormal phosphorylation of all six brain isoforms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.329: Neuron, 8, 159168.[ISI][Medline]

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "8,"

Phrase: "159168."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

